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Abstract 
Myocarditis and inflammatory dilated cardiomyopathy (DCMi) are major 
causes of heart failure in individuals below the age of 40. In the work 
presented in this dissertation, using a model of mouse experimental 
autoimmune myocarditis (EAM) and DCMi, the roles of four pathogenic 
factors: CD4+ T lymphocytes, interleukin 23 (IL-23), interleukin 17A (IL-
17A), and granulocyte macrophage colony-stimulating factor (GM-CSF), 
are investigated. With transgenic IL-23a-/- and IL-17ra-/- mice, we 
demonstrate that IL-23 drives the pathogenicity of CD4+ T cells and 
maintains their IL-17A production. IL-17A induces chemokine 
production by cardiac fibroblasts, resulting in an infiltrate rich in 
neutrophils and Ly6Chi MO/MΦs in the heart, which aggravate disease 
and lead to worse prognosis. Furthermore, IL-17A directs monocytic 
infiltrates into an even more inflammatory phenotype by inducing GM-
CSF production from cardiac fibroblasts. Taken together, this IL-23 – 
CD4+ T lymphocytes – IL-17A – GM-CSF axis provides a novel target for 
the treatment of DCMi and related inflammatory cardiac diseases. 
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Preface 
As a fan of detective fiction, I have always been fascinated by the 
similarities between biomedical research and the fictional world of 
detective mystery. In the world of fictional detectives, the likes of 
Sherlock Holmes encounter criminal cases, develop theories, interview 
witnesses, and collect evidence to uncover the truths behind crimes. In 
biomedical research, investigators design and conduct experiments, 
collect and analyze data to back up hypotheses, and discover the 
underlying mechanism of disease pathogenesis. Sherlock Holmes, the 
most famous fictional detective of all, is notorious for rarely showing 
empathy for the well being of victims of crime. Biomedical research, 
however, is fundamentally motivated by the welfare of the patients. 
Therefore, not only does biomedical research require exceptional 
reasoning skills, but it also bears a noble cause. The original Sherlock 
Holmes story of the Sign of the Four by Arthur Conan Doyle centered on a 
conspiracy involving a British soldier stationed in India and three local 
Sikhs. In this dissertation, the interactions between CD4+ T lymphocyte 
and three cytokines, interleukin 23, interleukin 17A and granulocyte 
macrophage colony-stimulating factors (GM-CSF), are investigated to 
reveal the pathogenesis of myocarditis and inflammatory dilated 
cardiomyopathy (DCMi). 
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Myocarditis: Etiology 
Myocarditis is the inflammation of myocardium, the cardiac muscle 
(Cooper, Leslie T., 2009). A broad range of immunopathologic processes 
may contribute to the development of disease; thus myocarditis is 
usually classified by cause and types of cardiac infiltrate determined by 
histology (Table I) (Sagar et al., 2011). 
Myocarditis is usually induced by infection or cardiotoxic chemicals. 
Parvovirus B19, Coxsackie B virus, Borrelia burgdorferi and Trypanosoma 
cruzi are among the most common pathogens associated with human 
myocarditis (Kindermann et al., 2012). Viral infection is most frequently 
implicated in myocarditis cases in the industrialized world. Presently, 
Parvovirus B19 is among the most prevalent viruses found in the heart 
tissue of acute myocarditis patients (Breinholt et al., 2010). Myocarditis 
caused by Trypanosoma cruzi infection poses particular health threat in 
South and Central America (Bocchi et al., 2013). As the distribution of its 
vector Reduviidae species spreads due to a shifting global climate, 
Trypanosoma cruzi may spread to previously unaffected places, such as 
the southern United States (Nunes et al., 2013). Mouse models have been 
established to study the pathogenesis of myocarditis caused by 
Coxsackie B virus and Trypanosoma cruzi (RABIN et al., 1964; Cihakova 
and Rose, 2008; Bonney and Engman, 2008). 
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Regardless of the etiology, autoimmunity is involved in the pathogenesis 
of many myocarditis patients (Schultheiss et al., 2011). The involvement 
of autoimmunity usually leads to prolonged immunopathology and a 
poor prognosis. Giant cell myocarditis is strongly associated with 
autoimmunity due to its connection with a variety of autoimmune-related 
disorders, such as celiac disease and systemic lupus erythematosus 
(Chung et al., 2005; Frustaci et al., 2002). Patients with giant cell 
myocarditis bear high likelihood of heart failure (Cihakova and Rose, 
2008), and immunosuppression has shown to be of benefit in the 
treatment of giant cell myocarditis (Kandolin et al., 2013). Anti-heart 
autoantibodies were found in the serum of many myocarditis patients 
(Caforio et al., 2008), further suggesting that autoimmunity may be 
important in human myocarditis. In addition, CD4+ T cells isolated from 
some myocarditis patients were reported to be activated by heart 
autoantigens (Kallwellis-Opara et al., 2007). 
There are different theories regarding the initiation of autoimmunity in 
myocarditis patients. The exposure of otherwise secluded autoantigens 
and the activation of immune system during infection both contribute to 
the induction of autoimmunity (Kindermann et al., 2012). In addition, 
some pathogens, such as Trypanosoma cruzi, express immunologic 
epitopes mimicking cardiac autoantigens, thus may also contribute to 
the induction of autoimmunity (Cunha-Neto et al., 2006). In chapter II of 
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this dissertation, the detailed mechanism of the induction of autoreactive 
CD4+ T cells will be examined in an animal model of human myocarditis. 
 
Myocarditis: Diagnosis 
Myocarditis can present with a wide range of symptoms from fatigue and 
mild chest pain to cardiac shock and death (Cooper, Leslie T., 2009). 
Blood tests for cardiac troponin I and creatine kinase MB, 
echocardiography, and cardiac MRI are all used in the diagnosis of 
myocarditis (Kindermann et al., 2012). However, since myocarditis 
presents no characteristic symptoms, it is usually diagnosed after other 
causes are excluded (Sagar et al., 2011). The gold standard for diagnosis 
is endomyocardial biopsy. According to the Dallas Criteria, the diagnosis 
of myocarditis rest on the presence of mononuclear infiltration and 
cardiomyocyte necrosis upon histopathological examination (Aretz et al., 
1987). However, because of the patchy nature of myocarditis, 
endomyocardial biopsy alone lacks sensitivity. Recently, cardiac MRI has 
been used to localize sites for endomyocardial biopsy in order to achieve 
higher sensitivity. In one study, MRI-guided biopsy was able to identify 
cardiac inflammation in 19 of 21 previously diagnosed myocarditis 
patients, while unguided endomyocardial biopsy alone only detected 
inflammation in less than 20% of the same patients (Abdel-Aty et al., 
2005). 
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Since the prognosis of myocarditis varies drastically from patient to 
patient, there have been attempts to develop reliable biomarkers to 
indicate the disease outcome and develop strategies for treatment. For 
instance, patients with high serum levels of soluble fatty acid synthase 
(FAS) and interleukin 10 (IL-10) were found to have worse outcomes 
(Sheppard et al., 2005; Nishii et al., 2004). However, these assays are not 
readily available clinically. In Chapter III of this dissertation, the prospect 
of new biomarkers for predicting the disease outcome will also be 
discussed. 
 
Inflammatory Dilated Cardiomyopathy 
The short-term prognosis of myocarditis is usually good. However, 
myocarditis patients may progress to inflammatory dilated 
cardiomyopathy (DCMi) (Cooper, Leslie T., 2009). In one long-term follow-
up study, 21% of acute myocarditis patients developed DCMi within 3 
years (D’Ambrosio et al., 2001). In DCMi patients, the damaged 
cardiomyocytes are replaced by scar tissue and the myocardium 
undergoes irreversible fibrosis and remodeling, making DCMi among the 
most common causes of non-congenital heart failure in individuals under 
the age of 40 (Dimas et al., 2009). There has been limited success with 
symptomatic therapy in chronic DCMi patients, such as angiotensin 
converting enzyme (ACE) inhibitors and ß adrenergic receptor blockers 
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treatment, leaving cardiac transplantation the only cure for end stage 
heart failure secondary to DCMi (Pietra et al., 2012). Recently, 
immunosuppressive drugs azathioprine and prednisone have been tested 
to treat DCMi without active viral infection. Compared with placebo, 
immune suppression significantly improved cardiac function in patients 
(Cooper et al., 2008). This finding support the view that immune 
responses are vital in the development of DCMi. In Chapter III of this 
dissertation, a detailed mechanism of how cardiac inflammation leads to 
DCMi will be proposed, and the prospect of this pathway as a new target 
for immune modulation will be discussed. 
 
Mouse Model of Experimental Autoimmune Myocarditis 
To investigate the immunopathologic mechanism responsible for 
myocarditis and DCMi in humans, we have adopted a mouse model of 
experimental autoimmune myocarditis (EAM). In BALB/c mice, EAM is 
induced by immunization with a peptide derived from the cardiac myosin 
heavy chain alpha (MyHCα614-629). A/J, A.SW, C3H and FVB/NF are also 
good responders to EAM. Immunized mice develop myocarditis 
characterized by inflammatory infiltration. Heart inflammation in this 
murine model starts about day 10 and peaks about day 21.  Immunized 
mice subsequently progress to DCMi around day 42 to day 63, which is 
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characterized by cardiac fibrosis and impaired cardiac function 
(Ciháková et al., 2004) (Figure 1). 
EAM is a CD4+ T helper cell-dependent disease (Smith and Allen, 1991, 
1993), as depletion of CD4+ T cells protects mice from EAM. CD4+ 
promotes the infiltration of other effector leukocytes populations, 
including CD8+ T cells, natural killer (NK) cells, neutrophils, eosinophils, 
monocytes and macrophages (Barin et al., 2012). Chapter II and III of 
this dissertation will interrogate the initiation of autoreactive CD4+ T cell 
response, and describe how CD4+ T cells direct the augmentation of the 
immune response and determine the prognosis of EAM. 
 
The Polarization of T Helper 17 Cells and Their Involvement in 
Experimental Autoimmune Myocarditis 
CD4+ T cells undergo different differentiation programs upon stimulation 
from their microenvironment (Figure 2). For instance, interleukin 12 (IL-
12) and interleukin 18 (IL-18) promote Th1 differentiation driven by 
transcription factor T-bet, while interleukin 4 (IL-4) and interleukin 33 
(IL-33) promote Th2 differentiation driven by GATA3 (Mukasa et al., 
2010). They play critical roles in immune responses against viral 
infections and during asthma (Maruyama et al., 2010).  
The polarization of CD4+ T cells was believed to be stable; however, 
recent studies underscore the plasticity of their differentiation (McAleer 
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and Kolls, 2011). Rather than being rigidly committed, under certain 
stimulations, differentiated CD4+ T cells can convert into new 
phenotypes by activating other polarization programs. For instance, one 
fate mapping study showed that in the mouse model, experimental 
autoimmune encephalomyelitis (EAE), most IFNγ- producing CD4+ T 
cells in the CNS were originally IL-17A – producing cells (Hirota et al., 
2011). 
Early studies have shown that neither Th1 nor Th2 program is the driver 
of EAM disease. Mice with deficiencies in the Th1 program, such as Ifng-/- 
and Tbx21-/- mice, develop even severer disease than wild-type (WT) mice 
(Rangachari et al., 2006; Afanasyeva et al., 2004). In addition, Il12a-/- 
mice develop disease comparable with WT controls (Afanasyeva et al., 
2001b). These results demonstrate that Th1 polarization is dispensable 
in the development of EAM, and may play a protective role in its 
pathogenesis. Th2 cytokines were found to aggravate EAM in A/J mice in 
an IL-4-dependent fashion (Afanasyeva et al., 2001a). However, they were 
protective in BALB/c mice by skewing the phenotype of macrophages 
(Cihakova et al., 2008). Thus, Th2 cells are not the primary driver of EAM. 
In recent years, another CD4+ T helper cell subset, Th17 cells, has been 
characterized and discovered to be critical in autoimmunity (Korn et al., 
2009). Th17 program is initiated by transforming growth factor ß (TGFß) 
and interleukin 6 (IL-6), and is further promoted by interleukin 1ß (IL-
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1ß) and interleukin 23 (IL-23) (Figure 3) (Gaffen, 2011). This combination 
of stimuli activates the FOXO, NFκB and STAT3 pathways, leading to the 
expression of master transcription factor retinoic acid receptor-related 
orphan receptor γt (RORγt) encoded by gene Rorc (Yang et al., 2008). 
RORγt switches on multiple Th17 effector molecules that play critical 
roles in autoimmunity (Zúñiga et al., 2013). Mice with a deficiency in the 
Rorc gene were resistant to autoimmune diseases (Maddur et al., 2012), 
demonstrating the pivotal roles Th17 cells play in autoimmunity. 
Th17 cells infiltrate the heart during EAM (Baldeviano et al., 2010). 
Furthermore, patients with DCMi have increased numbers of Th17 cells 
in their blood and elevated levels of Th17 cytokines in serum, suggesting 
that Th17 cells are involved in the pathogenesis of DCMi (Yuan et al., 
2010; Ding et al., 2010). This dissertation will look into how Th17 
program is induced during the induction of EAM, and the detailed 
downstream effector pathways that dictate disease outcomes. 
 
Interleukin 23 and the Differentiation of Th17 Cells 
IL-23 is critical in the maturation of Th17 cells. IL-23 is a heterodimer of 
subunits p19 and p40, encoded by genes Il23a and Il12b, respectively. It 
is recognized by IL-23 receptor (IL-23R) (Abraham and Cho, 2009). p19 
subunit is unique to IL-23 and determines the binding of IL-23 to its 
receptor, while p40 subunit is shared with IL-12. Antigen presenting 
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cells (APCs) are the main source of IL-23 (Kinnebrew et al., 2012). Upon 
activation by TGFß and IL-6, usually expressed by injured tissue, CD4+ 
T cells upregulate IL-23R and react to IL-23 signal from APCs (Kurschus 
et al., 2010). IL-23 induces the activation of STAT3 pathway, which 
further stabilizes the Th17 program and enhances the expression of 
major Th17 effector molecules (El-Behi et al., 2011a). Deficiencies in the 
IL-23 gene ameliorate experimental autoimmune encephalomyelitis (EAE) 
in mice (Becher et al., 2003), suggesting IL-23 is critical in the 
pathogenicity of Th17 cells. In chapter II of this dissertation, Il23a-/- mice 
will be employed to study the role IL-23 plays in the induction of 
pathogenic CD4 T cells and the initiation of EAM. 
 
Interleukin 17A: Signal Transduction and Roles in EAM 
Interleukin 17A (IL-17A), one of the Th17 effector molecules, is the 
hallmark cytokine produced by Th17 cells. IL-17A functions as a 
homodimer of two subunits and is recognized by receptor complex 
consisting of interleukin 17 receptor A (IL-17RA) and receptor C (IL-
17RC). IL-17RC dictates the affinity of IL-17RA/RC receptor complex to 
IL-17A, while IL-17RA is responsible for the signal transduction through 
its cytoplasmic tail. IL-17RA recruits the scaffold protein ACT1 via its 
SEFIR domain upon binding with ligands, and activates NFκB, MAPK 
and C/EBP pathways (Figure 4) (Ho et al., 2010). 
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IL-17A receptors are widely expressed among different cell types. 
However, stromal cells are found to be particularly sensitive to IL-17A 
stimulation (Gaffen, 2009). IL-17A induces the production of defensin ß2 
and lipocalin 2, which are critical in innate defense against extracellular 
fungal and bacterial infections (McAleer and Kolls, 2011). Human and 
mouse studies show that deficiencies in IL-17A and its receptor impair 
protection against Candida albicans and Staphylococcus aureus 
infections (Cho et al., 2010; Puel et al., 2011). In humans, APECED 
patients with impaired IL-17A functions are highly susceptible to 
Candida and Staphylococcus infections (Ng et al., 2010). 
Baldeviano et. al. reported that Il17a–/– mice were completely protected 
from the development of DCMi, although they had myocardial 
inflammation comparable in overall severity to wild-type (WT) controls 
(Baldeviano et al., 2010). Thus, IL-17A is dispensable for early stage 
myocarditis, but is required for the progression to DCMi. These results 
indicate a key role for IL-17A in driving cardiac damage and fibrosis 
during the development of DCMi. Similar profibrotic functions of IL-17A 
have been reported in cirrhosis (Lan et al., 2009) and fibrotic lung injury 
(Wilson et al., 2010) models. In Chapter III of this dissertation, a detailed 
mechanism by which IL-17A induces DCMi will be investigated. 
 
Monocytes and Macrophages 
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Monocytes (MOs) and macrophages (MΦs) are key effector cells during 
inflammatory processes (Gordon and Taylor, 2005) including myocarditis 
and DCMi.  
During embryonic development, cells originating in yolk sac, fetal liver, 
and bone marrow migrate into non-lymphoid organs and develop into 
stable populations of tissue resident macrophages (rMΦs) (Figure 5) 
(Epelman et al., 2014; Ginhoux et al., 2010; Guilliams et al., 2013). 
Tissue resident macrophages from different organs have unique 
characteristics and play critical roles in the homeostasis of their resident 
organs through adult life. Under normal conditions, tissue resident 
macrophages replenish themselves by local proliferation, with little 
contribution from the hematopoietic cells in the blood (Guilliams et al., 
2013). However, animal studies have shown that cells originating from 
bone marrow are able to replenish tissue resident macrophages under 
extraordinary circumstances when the latter are depleted, such as after 
irradiation (Yona et al., 2013).  
Monocytes arise from hematopoietic stem cells (HSCs) in the bone 
marrow. HSCs undergo several stages of development, through common 
myeloid progenitors (CMPs) and granulocyte/monocyte progenitors 
(GMPs), to differentiate into monocytes in the blood and lymphoid organs 
(Shi and Pamer, 2011). Some of these progenitor cells migrate from bone 
marrow to spleen and react rapidly to signals of inflammation, such as 
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myocardial infarction (MI), thereby replenishing the monocyte repository 
(Figure 5) (Leuschner et al., 2012). 
Monocytes form distinct subpopulations in blood (Table II) (Auffray et al., 
2009). In mouse, the two monocyte subsets, CCR2hiCX3CR1loLy6Chi and 
CCR2loCX3CR1hiLy6Clo monocytes, infiltrate sites of inflammation 
responding to different chemokine signals. There they differentiate into 
inflammatory macrophages (iMΦs) guided by local cytokine signals (Shi 
and Pamer, 2011) (Figure 5). Studies in MI and liver fibrosis models have 
shown that these two sub-populations have distinct properties and 
functions that may affect the progression and resolution of inflammation. 
In EAM, MO/MΦs comprise about half of all heart-infiltrating 
inflammatory cells at the peak of inflammation and play important roles 
in pathogenesis (Barin et al., 2012; Cihakova et al., 2008). The balance 
between MO/MΦ subsets and their differentiation is critical in 
determining the pathogenic outcome in EAM. In Chapter III of this 
dissertation, the connection between Th17 program and the balance of 
MO/MΦ subsets will be examined. 
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Figures and Tables 
Figure 1 Mouse model of experimental autoimmune myocarditis 
(EAM)  and inflammatory dilated cardiomyopathy 
 
Figure 2 Differentiation of CD4+ T cells   
15 
Figure 3 Th17 polarization of CD4+ T cells  
Figure 4 Signal transduction of IL-17A  
16 
Figure 5 Origin of tissue resident and inflammatory macrophages 
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Table I Selected Classifications of Myocarditis 
By Cause  
Viral Parvovirus B19, Coxsakie B Virus, HIV, HSV, etc. 
Bacterial Borrelia burgdorferi, Staphylococcus aureus, etc. 
Protozoal Trypanosoma cruzi, Toxoplasma gondii, Babesia, etc. 
Toxic Alcohol, arsenic, antibiotics and doxorubicin, etc 
By Types of Cardiac Infiltrate 
Lymphocytic  
Granulomatous  
Giant Cell  
Eosinophilic  
 
Modified from Sagar et. al. 2011  
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Table II Monocyte Heterogeneity  
In Human  
CD14hi CD16- 
Pro-inflammatory “classical” monocytes 
Antimicrobial functions 
CD14lo CD16hi 
“Non-classical” patrolling monocytes 
Homeostasis of blood vessel 
CD14hi CD16lo Intermediate monocytes 
In Mouse  
Ly6Chi CCR2hi CX3CR1lo 
Resemble human CD14hi CD16- monocytes 
Pro-inflammatory 
Ly6Clo CCR2lo CX3CR1hi 
Resemble human CD14lo CD16hi monocytes 
Homeostatic 
  
Modified from Gordon et. al. 2005  








Chapter II Interleukin 23 Is Required in the Induction of 
Experimental Autoimmune Myocarditis 
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2.1 Results 
Il23a-/- Mice Are Protected from EAM 
IL-23 is a heterodimer of subunits p19 and p40, encoded by genes Il23a 
and Il12b respectively, and is recognized by the IL-23 receptor (IL-23R). 
p19 subunit is unique to IL-23 and determines the binding of IL-23 to its 
receptor, while p40 subunit is shared with IL-12. In order to study the 
roles IL-23 plays in the pathogenesis of EAM, we employed Il23a-/- mice. 
Il23a-/-, Il23a+/- and wild-type (WT) BALB/c mice were immunized with 
the MyHCα614-629 peptide and sacrificed 21days post immunization. 
Histopathology of mouse hearts showed that Il23a-/- mice were fully 
protected from heart inflammation, whereas WT and Il23a+/- controls 
developed EAM (Figure 6A). Flow cytometric analysis revealed extensive 
infiltration of CD45+ leukocytes in the hearts of WT and Il23a+/- but not 
Il23a-/- mice (Figure 6B). In addition, cardiac inflammation in WT and 
Il23a+/- mice was accompanied by substantial expansion of myeloid 
effector cells, including Ly6Ghi neutrophils and Ly6G-CD11b+ monocytes 
in spleen and peripheral blood, while Il23a-/- mice were protected (Figure 
7). 
Interestingly, the ability of IL23a-/- mice to generate antibodies against 
MyHCα614-629 peptide used in immunization was not hampered by p19 
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deficiency, as their serum anti-MyHCα614-629 IgG titers were comparable 
with WT and IL23a+/- controls (Figure 8). 
In summary, Il23a-/- mice were protected from cardiac inflammation, 
which demonstrated that IL-23 is indispensable in the induction of EAM. 
 
IL-23 Deficiency Impairs Th17 Polarization during the Induction of 
EAM 
Since IL-23 has been shown to be critical in Th17 differentiation, we 
interrogated if IL-23 deficiency had any effect in CD4+ T cell polarization 
in the induction phase of EAM. 
Il23a-/- and Il23a+/- BALB/c mice were immunized in the hind limb and 
sacrificed 14 days post immunization. Flow cytometric analysis showed 
that Il23a-/- mice had significantly lower levels of IL-17A-producing CD4+ 
T cells in the draining lymph nodes of the sites of immunization (Figure 
9A). In contrast, the levels of IFNγ and IL-13 producing CD4+ T cells are 
comparable in Il23a-/- and Il23a+/- mice (Figure 9B and 9C). Interestingly, 
the levels of IL-17A / GM-CSF double producer CD4+ T cells showed a 
greater difference between the two groups (Figure 9D). A similar pattern 
was observed in the spleens of Il23a-/- and Il23a+/- mice (Figure 10). In 
addition, Il23a-/- mice had significantly lower levels of IL-17A in the 
serum (Figure 11A), while the levels of IL-13 were comparable with 
	   22 
Il23a+/- mice (Figure 11C). Il23a-/- mice also had a trend of lower levels of 
IFNγ  in the serum, albeit not statistically significant (Figure 11B), 
indicating that IFN γ  production during EAM may reflect heart 
inflammation. 
In summary, IL-23 deficiency impaired Th17 polarization program in the 
induction phase of EAM. These results indicate that Th17 polarization of 
CD4+ T cells is required for the induction of EAM. 
 
IL-23 is Not Required in EAM after Autoreactive CD4+ T Cell 
Population Is Established 
Previous results indicated that IL-23-dependent Th17 polarization was 
indispensable for the development of pathogenic autoreactive CD4+ T 
cells. In order to determine if IL-23 is still required to maintain the 
autoimmune response after pathogenic CD4+ T cells are generated, we 
used a CD4+ T cell transfer model of EAM disease. In this model, 
splenocytes were collected from immunized Thy1.1 donor mice 14 days 
post immunization, after the onset of cardiac inflammation. After 
culturing in a Th17 polarizing environment ex vivo for 4 days, CD4+ T 
cells were isolated and transferred intravenously into sublethally 
irradiated Thy1.2 recipients. Heart inflammation was examined 2 weeks 
after the transfer (Figure 12). 
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Histopathology showed that even without any IL-23 signal in the 
recipients, established autoreactive CD4+ T cells were able to induce 
heart inflammation in Il23a-/- mice comparable to WT recipients (Figure 
13A). Flow cytometric analysis showed that Il23a-/- recipients had levels 
of CD45+ cell infiltration comparable to WT controls (Figure 13B), and the 
compositions of infiltration cells were similar between two groups (Figure 
14). 
We next investigated the polarization of CD4+ T cells in different 
recipients. The vast majority of the heart-infiltrating CD4+ T cells were 
transferred Thy1.1+ donor cells (Figure 15A). Moreover, cytokine 
producing CD4+ T cells were almost exclusively of donor origin (Figure 
15B, 15C and 15D). These suggested that autoreactive CD4+ T cells used 
in transfer were highly pathogenic. Although transferred autoreactive 
CD4+ T cells were able to initiate cardiac inflammation in both WT and 
Il23a-/- mice, the cytokine production profiles were different between two 
groups. CD4+ T cells in Il23a-/- recipients produced significantly lower 
levels of IL-17A (Figure 16A) but higher levels of IFNγ (Figure 16B). 
These results suggested that although IL-23 was not required for the 
development of cardiac inflammation once autoreactive CD4+ T cell 
population was established, it was crucial in maintaining IL-17A 
production in pathogenic CD4+ T cells. Pathogenic CD4+ T cells would 
otherwise convert from IL-17A producers to IFNγ producers. However, 
these results also indicated that IL-17A and IFNγ production did not 
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affect EAM development once pathogenicity was already established, 
thus IL-17A and IFNγ may not be the “pathogenic” factor that donor 
CD4+ T cells produced during EAM. 
Although CD4+ T cells in the hearts of WT and Il23a-/- recipients differed 
in IL-17A and IFNγ production, the levels of GM-CSF producers were 
comparable in the two groups (Figure 16C), indicating that GM-CSF may 
play an important role in the development of cardiac inflammation 
during EAM.  
 
IL-23 from Various Sources Induces Pathogenicity in CD4+ T Cells 
We next used a dendritic cell (DC) transfer model to study the roles IL-23 
plays in the induction of pathogenic autoreactive CD4+ T cells. Bone 
marrow derived DCs (BMDCs) from WT or Il23a-/- donors were matured 
with LPS and loaded with MyHCα614-629 peptide. Loaded BMDCs, 0.1x106, 
were then subcutaneously injected in the hind limb of Il23a-/- or WT 
recipients. Heart inflammation was examined 2 weeks after transfer 
(Figure 17). 
Histopathology showed that WT BMDCs induced EAM in Il23a-/- 
recipients as well as Il23a-/- BMDCs in WT recipients (Figure 18). 
However, compared with Il23a-/- BMDCs in WT recipients, WT BMDCs 
were able to inducing higher levels of IL-17A-producing and IFNγ-
producing CD4+ T cells in the draining lymph nodes of the site of 
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injection (Figure 19). The difference in IL-17A and IFNγ production was 
not detected in the spleen (Figure 15). 
We conclude that these results indicate that transient IL-23 stimulation 
during the antigen presentation process is sufficient to induce 
autoreactive CD4+ T cells, as a small number of WT BMDCs were able to 
reinstate pathogenicity in Il23a-/- recipients. Second, IL-23 stimulation 
and antigen presentation could be separated in the induction of 
pathogenicity in CD4+ T cells, as Il23a-/- BMDCs were able to induce 
disease in WT recipients, and the difference in IL-17A production in 
draining lymph nodes disappeared once CD4+ T cells reached the spleen.  
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2.2 Discussion 
In this series of experiments we employed Il23a-/- BALB/c mice and 
demonstrated the requirement of IL-23 in the induction of cardiac 
inflammation in EAM. Deficiency of IL-23 impaired Th17 polarization, 
which was associated with resistance to EAM in Il23a-/- mice. The BMDC 
transfer model showed that transient IL-23 stimulation from a small 
number of antigen presenting cells was sufficient to generate pathogenic 
CD4+ T cells. However, IL-23 from other sources compensated for the 
lack of IL-23 during antigen presentation. Furthermore, IL-23 was 
dispensable in EAM once a pathogenic autoreactive CD4+ T cell 
population was established, whereas the ability of CD4+ T cells to 
continue producing IL-17A relied upon IL-23. 
These results confirmed previous findings that Il12b-/- but not Il12a-/- 
mice were protected from EAM (Afanasyeva et al., 2001b, Baldeviano, 
2010). Since p19 subunit is unique to IL-23, these results provided direct 
evidence that IL-23 is required in the induction of cardiac autoimmunity 
in EAM, adding to the increasing list of IL-23-dependent autoimmune 
disease models (Izcue et al., 2008; El-Behi et al., 2011b; Poppensieker et 
al., 2012). Since IL-23 deficiency directly impaired Th17 polarization 
program in CD4+ T cells, these results also strongly indicated that Th17 
cells drive the pathogenesis of EAM. 
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However, it is still unclear what factor produced by Th17 cells is 
responsible for the pathogenesis of EAM. The CD4+ T cell transfer 
experiments illustrated that although IL-23 was required in maintaining 
IL-17A production in autoreactive CD4+ T cells, the lack of it had no 
significant effect on pathogenicity, as Il23a-/- recipients developed disease 
comparable with WT controls. As will be demonstrated in Chapter III of 
this dissertation, IL-17A is dispensable in the development of EAM as 
well, further indicating that the pathogenicity of EAM does not rely on IL-
17A production. 
Resent studies in mouse EAE model have implicated that GM-CSF 
production by Th17 polarized CD4+ T cells is crucial in their 
pathogenicity (El-Behi et al., 2011a). The results above further indicated 
that GM-CSF production determines the pathogenicity of CD4+ T cells in 
EAM model as well. First, in the active immunization model of EAM, IL-
23 deficiency significantly impaired GM-CSF production in CD4+ T cells, 
concurrent with decreased heart pathology. Second, in the CD4+ T cell 
transfer model of EAM, although lack of IL-23 in recipients lowered IL-
17A production in CD4+ T cells, GM-CSF production remained the same, 
consistent with the unaffected disease outcome. 
Although IL-23 is not required once pathogenicity of autoreactive CD4+ T 
cells is established, IL-23 is indispensable in establishing pathogenicity. 
Therefore, it is possible that in order for CD4+ T cells to become a GM-
CSF producer and gain pathogenicity, they first have to undergo IL-23-
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dependent Th17 polarization program. Once GM-CSF production is 
established, IL-23 signaling is no longer required for pathogenicity.  
As suggested in CD4+ T cell transfer model of disease, Th17 polarized 
cells may convert from a IL-17A-producing phenotype towards a IFNγ-
producing phenotype. However, their pathogenicity was not significantly 
affected. Recent studies in the mouse EAE model discovered similar 
pattern (Annunziato and Romagnani, 2010). With the help of YFP 
reporter mice, it was reported that the majority of IFNγ-producing CD4+ 
T cells are converted from IL-17A producers (Hirota et al., 2011). All of 
these findings support the promise that the Th17 program plays a critical 
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2.3 Figures 
 
Figure 6. Il23a-/- mice were protected from EAM  
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Figure 11. IL-23 deficiency affected cytokine production 
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Figure 13. IL-23 was not required for EAM after the establishment of 
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Figure 14. IL-23 had no effect on the composition of heart-
infiltrating cells once pathogenic autoreactive CD4+ T cell 
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Figure 16. IL-23 was critical in directing cytokine production in 
autoreactive CD4+ T cells 
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Figure 19. IL-23 from APC was critical in directing cytokine 
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Figure 20. IL-23 from other sources was able to compensate 
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2.4 Figure Legends 
Figure 6. Il23a-/- mice were protected from EAM  
EAM was induced in WT, Il23a+/- and Il23a-/- mice. Mice were sacrificed 
21 days post-immunization. The composition of heart-infiltrating cells 
was analyzed by flow cytometry. 
(A) EAM in WT, Il23a+/- and Il23a-/- mice scored using H&E staining. Data 
points represent individual mice. Bars represent mean. Data are 
analyzed by Kruskal-Wallis test followed by Dunn’s procedure. 
(B) Total intracardiac CD45+ leukocytes in WT, Il23a+/- and Il23a-/- mice. 
Data points represent individual mice. Bars represent mean. Data are 
analyzed by one-way ANOVA followed by Tukey’s post-test. *, p<0.05. 
 
Figure 7. Il23a-/- mice were protected from myeloid expansion 
during EAM 
EAM was induced in WT, Il23a+/- and Il23a-/- mice. Mice were sacrificed 
21 days post-immunization. The composition of splenocytes and blood 
leukocyte count were analyzed by flow cytometry. 
(A) Ly6Ghi neutrophils as a proportion of total CD45+ leukocytes in in the 
spleen of WT, Il23a+/- and Il23a-/- mice. 
(B) Ly6G-CD11b+ MO/MΦs as a proportion of total CD45+ leukocytes in 
the spleen of WT, Il23a+/- and Il23a-/- mice. 
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(C) Blood leukocyte count in WT, Il23a+/- and Il23a-/- mice 
(A) ~ (C) Data points represent individual mice. Bars represent mean. 
Data are analyzed by one-way ANOVA followed by Tukey’s post-test. *, 
p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001. 
 
Figure 8. Ability to generate antibodies was not impaired by IL-23 
deficiency 
EAM was induced in WT, Il23a+/- and Il23a-/- mice. Mice were sacrificed 
21 days post-immunization. The titer of anti-MyHCα614~629 in the serum 
was measured by ELISA. Data points represent individual mice. Bars 
represent mean. Data are analyzed by one-way ANOVA followed by 
Tukey’s post-test. 
 
Figure 9. IL-23 deficiency impaired Th17 polarization in draining 
lymph nodes 
EAM was induced in Il23a+/- and Il23a-/- mice by immunization at the 
hind limb. Mice were sacrificed 14 days post-immunization. Lymphoid 
cells were collected from the inguinal lymph nodes and stimulated with 
PMA (50ng/mL) and ionomycin (500ng/mL). Cytokine production in 
CD4+ T cells was analyzed by flow cytometry.  
(A) IL-17A producer as a proportion of total CD4+ T cells. 
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(B) IFNγ producer as a proportion of total CD4+ T cells. 
(C) IL-13 producer as a proportion of total CD4+ T cells. 
(D) IL-17A and GM-CSF double producer as a proportion of total CD4+ T 
cells. 
(A) ~ (D) Data points represent individual mice. Bars represent mean. 
Data are analyzed by unpaired two-tailed Student’s t test. *, p<0.05; **, 
p<0.01. 
 
Figure 10. IL-23 deficiency impaired Th17 polarization in spleen 
EAM was induced in Il23a+/- and Il23a-/- mice by immunization at the 
hind limb. Mice were sacrificed 14 days post-immunization. Splenocytes 
were collected and stimulated with PMA (50ng/mL) and ionomycin 
(500ng/mL). Cytokine production in CD4+ T cells was analyzed by flow 
cytometry.  
(A) IL-17A producer as a proportion of total CD4+ T cells. 
(B) IFNγ producer as a proportion of total CD4+ T cells. 
(C) GM-CSF producer as a proportion of total CD4+ T cells. 
(D) IL-17A and GM-CSF double producer as a proportion of total CD4+ T 
cells. 
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(A) ~ (D) Data points represent individual mice. Bars represent mean. 
Data are analyzed by unpaired two-tailed Student’s t test. ****, p<0.0001. 
 
Figure 11. IL-23 deficiency affected cytokine production 
EAM was induced in WT, Il23a+/- and Il23a-/- mice. Mice were sacrificed 
21 days post-immunization. The levels of cytokines (A) IL-17A, (B) IFNγ 
and (C) IL-13 in the serum were measured by ELISA. Data points 
represent individual mice. Bars represent mean. Data are analyzed by 
one-way ANOVA followed by Tukey’s post-test. **, p<0.01. 
 
Figure 12. Schematic illustration of CD4+ T cell transfer model of 
EAM 
Thy1.1 donor mice were immunized with MyHC α 614~629 peptide. 
Splenocytes were collected from donor mice 14 days post immunization 
and cultured ex vivo with 50μg/mL MyHCα614~629, 20ng/mL rIL-23, 
10ng/mL rIL-1ß and 40mmol NaCl for 4 days. CD4+ T cells were isolated 
and transferred intravenously into WT or Il23a-/- Thy1.2 recipients 
irradiated by 500 Rad γ-radiation. Heart inflammation was examined 2 
weeks after the transfer. 
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Figure 13. IL-23 was not required for EAM after the establishment of 
pathogenic autoreactive CD4+ T cells 
Thy1.1 donor mice were immunized with MyHC α 614~629 peptide. 
Splenocytes were collected from donor mice 14 days post immunization 
and cultured ex vivo with 50μg/mL MyHCα614~629, 20ng/mL rIL-23, 
10ng/mL rIL-1ß and 40mmol NaCl for 4 days. CD4+ T cells were isolated 
and transferred intravenously into WT or Il23a-/- Thy1.2 recipients 
irradiated by 500 Rad γ-radiation. Heart inflammation in recipient mice 
was examined 2 weeks after the transfer by histopathology and flow 
cytometry. 
(A) EAM in WT and Il23a-/- recipients scored using H&E staining. Data 
points represent individual mice. Bars represent mean. Data are 
analyzed by Mann-Whitney U test. 
(B) Total intracardiac CD45+ leukocytes in WT and Il23a-/- recipients. 
Data points represent individual mice. Bars represent mean. Data are 
analyzed by unpaired two-tailed Student’s t-test. 
 
Figure 14. IL-23 had no effect on the composition of heart-
infiltrating cells once pathogenic autoreactive CD4+ T cell 
population was established 
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Thy1.1 donor mice were immunized with MyHC α 614~629 peptide. 
Splenocytes were collected from donor mice 14 days post immunization 
and cultured ex vivo with 50μg/mL MyHCα614~629, 20ng/mL rIL-23, 
10ng/mL rIL-1ß and 40mmol NaCl for 4 days. CD4+ T cells were isolated 
and transferred intravenously into WT or Il23a-/- Thy1.2 recipients 
irradiated by 500 Rad γ-radiation. Heart inflammation was examined 2 
weeks after the transfer. The composition of heart-infiltrating CD45+ 
leukocytes was analyzed by flow cytometry. 
(A) CD4+ T cell as a proportion of total CD45+ leukocytes. 
(B) Ly6Ghi neutrophils as a proportion of total CD45+ leukocytes. 
(C) Ly6G-CD11b+ MO/MΦs as a proportion of total CD45+ leukocytes. 
(D) Ly6Chi MO/MΦs as a proportion of Ly6G-CD11b+ MO/MΦs. 
(A) ~ (D) Data points represent individual mice. Bars represent mean. 
Data are analyzed by unpaired two-tailed Student’s t-test. 
 
Figure 15. Heart-infiltrating CD4+ T cells were predominantly of 
donor origin 
Thy1.1 donor mice were immunized with MyHC α 614~629 peptide. 
Splenocytes were collected from donor mice 14 days post immunization 
and cultured ex vivo with 50μg/mL MyHCα614~629, 20ng/mL rIL-23, 
10ng/mL rIL-1ß and 40mmol NaCl for 4 days. CD4+ T cells were isolated 
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and transferred intravenously into WT or Il23a-/- Thy1.2 recipients 
irradiated by 500 Rad γ-radiation. Heart inflammation was examined 2 
weeks after the transfer. The origin of heart-infiltrating CD4+ T cells was 
examined by flow cytometry analysis of surface marker Thy1. 
(A) Thy1.1+ donor cells as a proportion of total CD4+ T cell. 
(B) Thy1.1+ donor cells as a proportion of IFNγ+ CD4+ T cell. 
(C) Thy1.1+ donor cells as a proportion of IL-17A+ CD4+ T cell. 
(D) Thy1.1+ donor cells as a proportion of GM-CSF+ CD4+ T cell. 
(A) ~ (D) Data points represent individual mice. Bars represent mean. 
Data are analyzed by unpaired two-tailed Student’s t-test. 
 
Figure 16. IL-23 was critical in directing cytokine production in 
autoreactive CD4+ T cells 
Thy1.1 donor mice were immunized with MyHC α 614~629 peptide. 
Splenocytes were collected from donor mice 14 days post immunization 
and cultured ex vivo with 50μg/mL MyHCα614~629, 20ng/mL rIL-23, 
10ng/mL rIL-1ß and 40mmol NaCl for 4 days. CD4+ T cells were isolated 
and transferred intravenously into WT or Il23a-/- Thy1.2 recipients 
irradiated by 500 Rad γ-radiation. Heart inflammation was examined 2 
weeks after the transfer. Single cell suspension of mouse hearts was 
stimulated with PMA (50ng/mL) and ionomycin (500ng/mL). The 
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cytokine production profile of heart-infiltrating CD4+ T cells was 
analyzed by flow cytometry. 
(A) IL-17A producers as a proportion of total CD4+ T cell. 
(B) IFNγ producers as a proportion of total CD4+ T cell. 
(C) GM-CSF producers as a proportion of total CD4+ T cell. 
(A) ~ (C) Data points represent individual mice. Bars represent mean. 
Data are analyzed by unpaired two-tailed Student’s t-test. **, p<0.01; ****, 
p<0.0001. 
 
Figure 17. Schematic illustration of BMDC transfer model of EAM 
Bone marrow derived DCs (BMDCs) from WT or Il23a-/- donors were 
matured with LPS and loaded with MyHCα614-629 peptide. 0.1x106 loaded 
BMDCs were then subcutaneously injected under the skin of hind limb 
of Il23a-/- or WT recipients. Heart inflammation was examined 2 weeks 
after transfer. 
 
Figure 18. IL-23 from various sources induced pathogenicity 
Bone marrow derived DCs (BMDCs) from WT or Il23a-/- donors were 
matured with LPS and loaded with MyHCα614-629 peptide. 0.1x106 loaded 
BMDCs were then subcutaneously injected under the skin of hind limb 
of Il23a-/- or WT recipients. Heart inflammation was examined 2 weeks 
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after transfer by H&E staining. Data points represent individual mice. 
Bars represent mean. Data are analyzed by Mann-Whitney U test. 
 
Figure 19. IL-23 from APC was critical in directing cytokine 
production in CD4+ T cells locally 
Bone marrow derived DCs (BMDCs) from WT or Il23a-/- donors were 
matured with LPS and loaded with MyHCα614-629 peptide. 0.1x106 loaded 
BMDCs were then subcutaneously injected under the skin of hind limb 
of Il23a-/- or WT recipients, repeated twice subsequently. Recipient mice 
were sacrificed 14 days after the last transfer. Lymphoid cells were 
collected from the inguinal lymph nodes and stimulated with PMA 
(50ng/mL) and ionomycin (500ng/mL). Cytokine production in CD4+ T 
cells was analyzed by flow cytometry.  
(A) IL-17A producer as a proportion of total CD4+ T cells. 
(B) IFNγ producer as a proportion of total CD4+ T cells. 
(A) and (B) Data points represent individual mice. Bars represent mean. 
Data are analyzed by unpaired two-tailed Student’s t test. *, p<0.05; ***, 
p<0.001 
 
Figure 20. IL-23 from other sources was able to compensate 
deficiency in APCs 
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Bone marrow derived DCs (BMDCs) from WT or Il23a-/- donors were 
matured with LPS and loaded with MyHCα614-629 peptide. 0.1x106 loaded 
BMDCs were then subcutaneously injected under the skin of hind limb 
of Il23a-/- or WT recipients, repeated twice subsequently. Recipient mice 
were sacrificed 14 days after the last transfer. Splenocytes were 
stimulated with PMA (50ng/mL) and ionomycin (500ng/mL). Cytokine 
production in CD4+ T cells was analyzed by flow cytometry.  
(A) IL-17A producer as a proportion of total CD4+ T cells. 
(B) IFNγ producer as a proportion of total CD4+ T cells. 
(A) and (B) Data points represent individual mice. Bars represent mean. 
Data are analyzed by unpaired two-tailed Student’s t test. 
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2.5 Materials and Methods 
Mice 
Il23a-/- founder mice were provided by Wyeth Inc and backcrossed with 
BALB/c for 10 generations. WT BALB/cJ and CBy.PL(B6)-Thy1a/ScrJ 
(Thy1.1) mice were purchased from the Jackson Laboratory. All mice 
were maintained in the Johns Hopkins University School of Medicine 
specific-pathogen free vivarium. Experiments were conducted on 6-10 
week old male mice, in compliance with the Animal Welfare Act and the 
principles set forth in the Guide for the Care and Use of Laboratory 
Animals. All methods and protocols are approved by the Animal Care and 
Use Committee of The Johns Hopkins University. 
Induction of EAM  
We employed the myocarditogenic peptide of cardiac myosin heavy chain, 
MyHCα614-629 (Ac-SLKLMATLFSTYASAD), commercially synthesized by 
fMOC chemistry and purified to a minimum of 90% by HPLC (Genscript). 
On days 0 and 7, mice received an axillary subcutaneous immunization 
of 100 µg of MyHCα614-629 peptide emulsified in complete Freund’s 
adjuvant (CFA) (Sigma) supplemented to 5 mg/mL of heat-killed 
Mycobacterium tuberculosis strain H37Ra (Difco). On day 0, mice also 
received 500 ng of pertussis toxin intraperitoneally. (List Biologicals). 
For CD4+T cell transfer of EAM, Thy1.1 donor mice were immunized with 
MyHCα614~629 peptide. Splenocytes were collected from donor mice 14 
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days post immunization and cultured ex vivo in Dulbecco’s modified 
Eagle’s medium (DMEM) with 4.5g/L glucose, 2mM L-Glutamine, 1mM 
sodium pyruvate, 25mM HEPES, 100U/mL penicillin G, 100µg/mL 
streptomycin, 55µM 2-mercaptoethanol and 10% fetal bovine serum 
(FBS) supplemented with 50μg/mL MyHCα614~629, 20ng/mL rIL-23, 
10ng/mL rIL-1ß and 40mmol NaCl for 4 days. CD4+ T cells were isolated 
and transferred intravenously into WT or Il23a-/- Thy1.2 recipients 
irradiated by 500 Rad γ-radiation. Heart inflammation was examined 2 
weeks after the transfer. 
Assessment of EAM Histopathology  
Mice were evaluated for the development of EAM on day 21. Heart tissues 
were fixed in SafeFix solution (Fisher Scientific). Tissues were embedded 
longitudinally, and 5 µm serial sections were cut and stained with 
hematoxylin and eosin (H&E) (HistoServ, Gaithersburg, MD). Myocarditis 
severity was evaluated by H&E staining of myocardium area infiltrated 
with hematopoietic cells, according to the following scoring system: grade 
0, no inflammation; grade 1, less than 10% of the heart section is 
involved; grade 2, 10-25%; grade 3, 25-50%; grade 4, 50-75%; grade 5, 
more than 75%. Grading was performed by grading five sections per 
heart by two independent, blinded investigators and averaged.  
Flow Cytometry Analysis and FACS Isolation of Heart Infiltrating 
Cells  
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For Flow cytometry analysis, single cell suspension were made from mice 
hearts perfused for 3 min with 1x phosphate buffered saline (PBS) + 0.5% 
FBS, and digested in GentleMACS C Tubes according to manufacturer’s 
instructions (Miltenyi Biotec). Viability was determined by LIVE/DEAD 
staining according to manufacturer’s instructions (Life Techonologies). 
Cells were blocked with αCD16/32 (eBiosciences), and surface markers 
were stained with fluorochrome-conjugated mAbs (eBioscience, BD 
Pharmingen, BioLegend). Samples were acquired on the LSR II cytometer 
running FACSDiva 6 (BD Immunocytometry). Data were analyzed with 
FlowJo 7.6 (Treestar Software). 
Real-Time Quantitative PCR  
Tissue total RNA was extracted in TRIZOL (Life Technologies). cDNA were 
synthesized with High Capacity cDNA Reverse Transcription Kit (Life 
Technologies) and amplified with Power SYBR Green Mastermix (Life 
Technologies) in MyiQ2 thermocycler (Bio-Rad) running iQ5 software 
(Bio-Rad). Primer sequences are detailed in Supplemental Data. Data 
were analyzed by the 2–ΔΔCt method of Livak, et al., comparing 
threshold cycles first to Hprt expression, then ΔCt of target genes in 
controls. 
EAM Induction by Bone Marrow Derived Dendritic Cells  
Bone marrow cells from femur and tibia were isolated from adult wild-
type (WT) or Il23a-/- BALB/cJ mice and cultured in DMEM with 4.5g/L 
	   53 
glucose, 2mM L-Glutamine, 1mM sodium pyruvate, 25mM HEPES, 
100U/mL penicillin G, 100µg/mL streptomycin, 55µM 2-
mercaptoethanol and 10% FBS supplemented with 10ng/mL 
recombinant GM-CSF (R&D Systems) for 8 days. 
Bone marrow derived DCs (BMDCs) were matured with LPS and loaded 
with MyHCα614-629 peptide. Loaded BMDCs, 0.1x106, were then 
subcutaneously injected in the hind limb of Il23a-/- or WT recipients. A 
total of 3 injections were performed with a 2-day interval. Heart 
inflammation was examined 2 weeks after transfer. 
ELISA  
Quantitative sandwich ELISA for cell culture supernatants were 
determined by colorimetric ELISA kits according to manufacturers’ 
recommended protocols (R&D Systems). 
Statistics  
Normally distributed data were analyzed by two-tailed Student’s t-test 
(up to two groups) or one-way ANOVA followed by Tukey’s post-test. EAM 
severity scores were analyzed by Mann-Whitney U test (up to two groups) 
or Kruskal-Wallis test followed by Dunn’s procedure. Values of p < 0.05 
were considered statistically significant. 
  








Chapter III Cardiac Fibroblasts Mediate Interleukin 17A – 
Driven Inflammatory Dilated Cardiomyopathy 
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3.1 Results 
IL-17A/IL-17RA Signaling Is Required for the Development of DCMi 
We previously demonstrated that Il17a-/- mice are susceptible to EAM 
but are protected from DCMi (Baldeviano et al., 2010). In order to 
investigate the downstream functions of IL-17A in the development of 
DCMi, we first excluded the possibility that other IL-17 family cytokines 
signaling though the IL-17 receptor contributed to the DCMi phenotype 
by comparing disease in Il17ra–/– and Il17a–/– mice. Similar to Il17a-/- 
mice, Il17ra-/- mice were fully protected from DCMi after immunization 
with myocarditogenic peptide MyHCα614-629 (Figure 21), although they 
developed myocarditis histologically comparable to WT controls (Figure 
22). Il17ra-/- mice developed limited cardiac fibrosis while WT mice hearts 
had significant fibrosis as determined by Mason’s Trichrome staining 
(Figure 21A, 21B) and hydroxyproline assay (Figure 21C). In addition, 
Il17ra-/- mice retained normal heart function and were protected from 
ventricular dilation (Figure 21D, 21E and 23). Thus, we established that 
the IL-17A/IL-17RA signaling pathway is required for the development of 
DCMi. Moreover, since Il17ra–/– mice had disease similar to Il17a–/– mice, 
it is unlikely that other cytokines of the IL-17 family are critical in the 
pathogenesis of DCMi. 
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IL-17RA Deficiency Alters the Composition of Heart-Infiltrating 
Myeloid Populations during EAM 
Histopathologic and flow cytometric analyses (Figure 24A) revealed that 
Il17ra-/- mice had a similar degree of inflammation and quantitatively 
comparable numbers of heart-infiltrating CD45+ cells as WT controls 
(Figure 24B). There was no significant difference in the percentages of 
infiltrating CD4+ T cells or SiglecF+ eosinophils (Figure 25A, 25B). 
However, IL-17RA deficiency led to profound changes in the composition 
of infiltrating myeloid cells. Specifically, Il17ra-/- mice had significantly 
diminished Ly6Ghi neutrophil infiltration in their hearts (Figure 24C). 
Moreover, even though the proportion of total Ly6G-CD11b+ 
monocyte/macrophage (MO/MΦ) population in CD45+ cells was 
comparable (Figure 24D), Il17ra-/- mice had significantly lower levels of 
Ly6Chi population and higher levels of Ly6Clo population within the Ly6G-
CD11b+ MO/MΦ compartment (Figure 24E, 24F). Importantly, this shift 
in MO/MΦ populations was restricted to the heart, as the levels of Ly6Chi 
and Ly6Clo monocytes in the spleen were comparable between WT and 
Il17ra-/- mice (Figure 25C and data not shown). This was dissimilar to the 
reduction in cardiac infiltration of Ly6Ghi neutrophils, which was also 
detected in the spleen (Figure 25D). The specificity of the difference in the 
ratio of Ly6Chi to Ly6Clo MO/MΦs in the heart indicates that local but not 
systemic signals drive this change. In summary, protection from DCMi in 
Il17ra-/- mice is closely associated with the composition of myeloid 
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populations in the heart, particularly with a significant diminution of 
neutrophils and Ly6Chi monocytes. 
 
Intracardiac Ly6Chi MO/MΦs Have Proinflammatory and Profibrotic 
Phenotype while Ly6Clo MO/MΦs Upregulate IGF-1 and MMP 
Production 
The striking decrease in the ratio of Ly6Chi to Ly6Clo MO/MΦs in the 
absence of IL-17RA signaling led us to examine the contribution of these 
cell subsets to cardiac damage and fibrosis during DCMi development. 
Using FACS, we isolated CD45+Ly6G-CD11b+Ly6Chi and CD45+Ly6G-
CD11b+Ly6Clo MO/MΦs separately from WT mouse hearts at the peak of 
inflammation on day 21. Transcriptome profiles were generated by real-
time quantitative PCR (qPCR) analysis of these two populations (Figure 
26A, Table III).  
Ly6Chi MO/MΦs were characterized by higher Ccr2 expression. 
Compared to the Ly6Clo pupulation, Ly6Chi MO/MΦs produced higher 
levels of several proinflammatory cytokines and enzymes (Il1b, Il6, Il12a, 
Tnf and Nos2). In addition, Ly6Chi MO/MΦs upregulated 
thrombospondin-1 (Thbs1), which activates latent TGFβ trapped in the 
extracellular matrix (ECM) and initiates TGFβ-dependent fibrosis 
pathways (Frangogiannis, 2012). Ly6Chi MO/MΦs also produced more 
arginase 2 (Arg2) and YM1 (Chi3l3), which are traditionally associated 
with M2 tissue-repair macrophages, indicating that the classic M1/M2 
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dichotomy does not perfectly fit with Ly6Chi/Ly6Clo MO/MΦ phenotypes 
in the cardiac inflammation scenario during EAM and DCMi. Conversely, 
Ly6Clo MO/MΦs are characterized by greater expression of Cx3cr1, and 
they produced higher levels of matrix metalloproteinases (Mmp9 and 
Mmp12) and Insulin-like Growth Factor-1 (Igf1) (Figure 26A). These 
molecules have been implicated in protecting against tissue fibrosis by 
breaking down excessive ECM (Ramachandran et al., 2012) as well as by 
other mechanisms (Bessich et al., 2013). 
To summarize, heart-infiltrating Ly6Chi MO/MΦs display a 
proinflammatory and profibrotic phenotype indicating a pathogenic role, 
while Ly6Clo MO/MΦs produced high level of MMPs and IGF-1 suggesting 
a protective role. Therefore, Il17ra-/- mice had significantly less 
inflammatory monocytic infiltration in their hearts during the peak of 
inflammation, which helps to explain their resistance to DCMi. 
 
Ly6Chi MO/MΦs Aggravate DCMi 
In order to test the hypothesis that Ly6Chi MO/MΦs directly promote 
DCMi, we manipulated the balance of Ly6Chi and Ly6Clo MO/MΦs in vivo 
using two previously published methods. First, we injected mice with 
clodronate-loaded liposomes, which have been shown to induce 
apoptosis in MO/MΦs (van Rooijen et al., 1996). Second, we injected 
mice with PBS-loaded liposomes, which have been reported to induce a 
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phenotypic switch from Ly6Chi to Ly6Clo MO/MΦs through the 
phagocytosis of the liposomes (Ramachandran et al., 2012).  
To assess how these treatments affect the myocarditis phase of EAM, we 
injected PBS-loaded or clodronate-loaded liposomes on days 14, 16, 18, 
and 20 of EAM, and sacrificed the mice on day 21. PBS-loaded liposomes 
significantly reduced the proportion of Ly6Chi MO/MΦs among all Ly6G-
CD11b+ MO/MΦs (Figure 26B) and dramatically lowered the ratio of 
Ly6Chi to Ly6Clo MO/MΦs (Figure 26C), while not affecting the total 
number of Ly6G-CD11b+ MO/MΦs among heart-infiltrating CD45+ cells 
(Figure 26D). Clodronate-loaded liposomes, however, significantly 
decreased the total number of Ly6G-CD11b+ MO/MΦs in the hearts 
(Figure 26D), but also disproportionately reduced the proportion of 
Ly6Chi MO/MΦs among MO/MΦs (Figure 26B) and lowered the Ly6Chi to 
Ly6Clo MO/MΦ ratio (Figure 26C). Both PBS-loaded and clodronate-
loaded liposome treatments had no significant effect on the severity of 
EAM on day 21 (Figure 27A), and the levels of Ly6Ghi neutrophil 
infiltration in the heart were not affected (Figure 27B).  
We next administered PBS- or clodronate-loaded liposomes intravenously 
every other day from day 14 to day 35 of EAM, through the peak of 
cardiac inflammation, and assessed the severity of DCMi at day 63. 
Clodronate-loaded liposomes protected mice from the deterioration of 
cardiac function (Figure 26E, 27C and 27D). PBS-loaded liposomes also 
showed promising effects (Figure 26E, 27C and 27D), as none of the 
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PBS-loaded liposome treated mice developed severe DCMi defined by an 
ejection fraction lower than 60% (Figure 26E). Furthermore, mice treated 
with PBS-loaded or clodronate-loaded liposomes had significantly 
reduced cardiac enlargement (Figure 26F) and fibrosis (Figure 26G). 
These results illustrate that while Ly6Chi MO/MΦs are not required in 
the pathogenesis of acute myocarditis, they play critical roles in cardiac 
fibrosis and the development of DCMi. 
 
IL-17A/IL-17RA Signaling to Cardiac-Resident Cells Is Required for 
the Development of DCMi 
Protection of Il17ra–/– mice against DCMi is associated with significant 
diminution in neutrophil and Ly6Chi monocyte infiltration. In the 
inflamed heart, IL-17A receptors are expressed by both infiltrating 
hematopoietic cells (Gaffen, 2009) and cardiac resident cells (Figure 29A). 
To determine whether IL-17A drives DCMi by directly signaling to 
infiltrating hematopoietic cells or indirectly through cardiac-resident cells, 
we generated bone marrow chimeras. WT or Il17ra-/- bone marrows were 
transferred into lethally irradiated Il17ra-/- or WT recipients to generate 
bone marrow chimeras with IL-17RA signaling ablated in either 
hematopoietic or non-hematopoietic compartments (Figure 28A). 
Syngeneic transfers were performed as controls to exclude the effects of 
the bone marrow reconstruction itself. Chimeras lacking IL-17RA on 
their cardiac resident cells were protected from DCMi, regardless of the 
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genotype of their bone marrow donors. Their hearts retained normal 
function (Figure 28B, 29B, 29C) with lower levels of collagen deposition 
in their hearts (Figure 28C). Two-way ANOVA (genotype of recipients vs 
genotype of donors) confirmed the genotype of recipient mice as the 
primary source of variance. Chimeras lacking IL-17RA signaling in their 
hematopoietic compartment showed partially mitigated DCMi compared 
with WT syngeneic transfer controls; however, they were not fully 
protected from DCMi as the chimeras with Il17ra-/- bone marrows (Figure 
28B, 28C), suggesting IL-17RA signaling to hematopoietic cells is 
dispensable in the development of DCMi. 
 
IL-17A/IL-17RA Signaling to Cardiac-Resident Cells Results in 
Neutrophil and Ly6Chi MO/MΦ - Rich Infiltrate  
We observed that protection from DCMi in Il17ra–/– mice was associated 
with diminished neutrophils and Ly6Chi monocyte infiltration (Figure 24). 
To examine if this alteration in the cardiac infiltrate is due to IL-17A 
signaling to cardiac resident cells, we analyzed the composition of heart 
infiltrating cells in chimeras at the peak of inflammation on day 21. Flow 
cytometric analysis showed that lack of IL-17RA signaling in non-
hematopoietic cardiac residents cells diminished neutrophil and Ly6Chi 
MO/MΦ infiltration, mirroring our finding in Il17ra-/- mice hearts (Figure 
28D, 28E). Thus, IL-17RA signaling in cardiac-resident cells is mainly 
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responsible for regulating the composition of myeloid cells in the cardiac 
infiltrate, and is required for cardiac fibrosis during DCMi pathogenesis.  
 
IL-17A Fails to Induce Apoptosis in Adult Mouse Cardiomyocytes 
Having established that IL-17A signaling to cardiac resident cells is 
essential in driving cardiac damage and fibrosis during DCMi, we sought 
to identify the specific cell target of IL-17A. We isolated primary 
cardiomyocytes (CMs) from adult WT mice and stimulated them with 
recombinant IL-17A (rIL-17A) in vitro. After 24 hours, we assessed CM 
viability and morphology. A recent study found that IL-17A was able to 
induce apoptosis in neonatal CMs in vitro, and the authors suggested 
that this effect contributed to CM death during myocardial infarction in 
adults (Liao et al., 2012). However, adult CMs stimulated with rIL-17A 
retained their viability and morphology when compared to unstimulated 
CM culture (Figure 30A, 30B). Thus, IL-17A does not induce apoptosis in 
primary adult CMs in vitro. In addition, qPCR assay of CM mRNA did not 
detect any induction of classic IL-17A targets, including Il6 and Cxcl1 
(data not shown). Previous studies suggested that TNFα synergizes with 
IL-17A by stabilizing mRNA of IL-17A targets (Ruddy et al., 2004). 
However, addition of rTNFα to the culture did not induce activation of IL-
17A targets either (data not shown). IL-17A signals through the classical 
NF-κB pathway, which requires the degradation of NF-κB inhibitor IκBα 
(Gaffen, 2009). Yet, western blot showed that IL-17A failed to induce IκBα 
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degradation in CMs (Figure 30C). To summarize, IL-17A does not appear 
to have any significant effects on CMs in vitro, indicating CMs are not the 
primary IL-17A target during DCMi. 
 
IL-17A Induces Myeloid Chemokines and Cytokines Production from 
Cardiac Fibroblasts 
Next, we assessed the effect of IL-17A signaling to cardiac fibroblasts 
(CFs). We isolated primary CFs from WT adult mice and tested the purity 
of CF culture to rule out the possibility of contamination by macrophages 
and other cells. Bone marrow-derived macrophages (BMDMs) were used 
as a positive control. First, using immunofluorescence microscopy, we 
found that cells in our CF culture expressed α-smooth muscle actin 
(αSMA) but not myeloid marker CD11b (Figure 31A). Second, by flow 
cytometry, we did not detect any CD45+ leukocytes in our culture 
contaminating the CD44+ CF population (Figure 31B). Third, by qPCR, 
we detected the expression of fibroblast-specific genes Agtr1a 
(angiotensin II receptor, type 1a) and Ddr2 (discoidin domain receptor 
family member 2) in CF culture, but not myeloid-specific genes Ccr2, 
Cx3cr1, Mpo or Pgcd1lg2 (PD-L2) (Table S2). Based on the sensitivity of 
qPCR assay and the number of cells in the culture, macrophage 
contamination in CF culture, if any, is extremely low. 
To assess the effect of IL-17A on CFs, we isolated primary CFs from adult 
WT mice and stimulated with IL-17A for 24 hours. IL-17A was able to 
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induce the production of CXCL1, CCL2, GM-CSF, G-CSF, IL-6 and 
leukemia inhibitory factor (LIF) (Figure 31C), but not IL-1β, IL-33, TNFα, 
TGFβ, CCL8 and CCL11 (data not shown). Addition of TNFα further 
enhanced the stimulatory effects of IL-17A (Figure 31C). Interrogation of 
mRNA levels by qPCR confirmed these effects (Figure 32A). However, IL-
17A failed to directly stimulate the production of collagen in CFs (Figure 
32B), indicating that a more complex mechanism was involved in 
regulating fibrosis during IL-17A-driven DCMi. 
To confirm these results in vivo, we next isolated CD45-
CD34+CD146+CD44hiCD31- CFs from the hearts of immunized WT and 
Il17ra-/- mice by FACS (Figure 33A). qPCR analysis showed that CFs from 
Il17ra-/- mice expressed significantly lower levels of Cxcl1, Csf2, Csf3, and 
Il6 compared with CFs from WT mice (Figure 33B), confirming our in vitro 
findings that IL-17A stimulated the production of proinflammatory 
cytokines and chemokines in CFs. However, the levels of Ccl2 and Lif 
were comparable between CFs from WT and Il17ra-/- mice (Figure 34A), 
indicating more complex pathways were involved. Endothelial cells (ECs) 
have also been reported to respond to IL-17A signals. We therefore also 
isolated CD45-CD34+CD146+CD44loCD31hi ECs by FACS from the hearts 
of WT mice on day 21 of EAM (Figure 33A). qPCR analysis showed that 
the mRNA levels of proinflammatory cytokines and chemokines of 
interest were dramatically higher in CFs than ECs, with the exception of 
Csf3 (Figure 34B), indicating that, among cardiac resident cells, CFs are 
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the dominant source of proinflammatory cytokines and chemokines upon 
IL-17A stimulation during EAM and DCMi.  
CXCL1 is a major chemokine for neutrophil chemotaxis, and the 
induction of CXCL1 in CFs by IL-17A helps explain the differences in the 
composition of heart-infiltrating myeloid cells between Il17ra-/- and WT 
mice. IL-17A however did not have a significant effect on CX3CL1 
expression (Figure 32C), indicating that other mechanisms are involved 
in the accumulation of Ly6Clo monocytes in Il17ra-/- hearts. Moreover, 
GM-CSF, G-CSF and IL-6 play important roles in the differentiation and 
activation of myeloid cells, suggesting further interactions of CFs and 
inflammatory cells under IL-17A stimulation. 
 
IL-17A Is Able to Drive the Differentiation of Monocytes in trans 
through Cardiac Fibroblasts 
To determine whether IL-17A is able to instruct the differentiation of 
monocytes by inducing cytokine production from CFs, we designed an in 
vitro fibroblast - monocyte co-culture system. Since spleen is the major 
reservoir of monocytes during cardiac inflammation (Swirski et al., 2009), 
Ly6G-CD11c-CD11b+F4/80-Ly6Chi monocytes were FACS sorted from 
naïve Il17ra-/- mouse spleen and co-cultured with primary adult mouse 
CFs. In order to exclude direct signaling of IL-17A to monocytes, we used 
Il17ra-/- mice as monocyte donors. Il17ra-/- Ly6Chi monocytes were co-
cultured with WT CFs for 48 hours with or without rIL-17A stimulation. 
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Since monocytes themselves produce TNFα, no rTNFα was added to the 
cultures. After 48 hours of co-culture, monocytes were separated from 
CFs by FACS. qPCR assay of monocytes showed that, through its effects 
on CFs, IL-17A was able to indirectly upregulate proinflammatory genes 
Il1b, Il6, Il12a and Nos2, while downregulating suppressive gene Il10 
(Figure 35A). We repeated the experiment with Il17ra-/- CFs. rIL-17A 
failed to induce significant difference in Il17ra-/- monocytes (Figure 36) 
without responding CFs, demonstrating that these effects were IL-17A-
specific. IL-17A however could not induce de novo conversion of Ly6Clo 
MO/MΦs to Ly6Chi MO/MΦs either directly or indirectly through CFs. 
rIL-17 failed to affect Ly6Chi to Ly6Clo ratio in Ly6G-CD11c-
CD11b+F4/80- monocytes isolated from the spleen of WT mice (Figure 
35B). Co-culture of splenic Ly6G-CD11c-CD11b+F4/80- monocytes from 
Il17ra-/- mice with WT CFs resulted in lower level of Ly6Chi MO/MΦs, 
likely due to phagocytosis-induced conversion. However, addition of rIL-
17A had no additional effects (Figure 35C). 
Thus, IL-17A induced proinflammatory changes in Ly6Chi monocytes 
indirectly through CFs, suggesting that CFs actively participate in 
immune response and serve as a mediator between IL-17A and Ly6Chi 
monocytes. 
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IL-17A Drives the Differentiation of Monocytes by Inducing GM-CSF 
Production in Cardiac Fibroblasts 
We have shown that IL-17A induces the production of IL-6, G-CSF and 
GM-CSF from CFs (Figure 31C and 33B), which are all potent drivers of 
myeloid cells differentiation and activation. We therefore blocked these 
cytokines with neutralizing antibodies in our CF/monocyte co-culture 
system to determine which cytokine is the main transducer of the IL-17A 
signals to monocytes. Anti-IL-6RA monoclonal antibody (mAb) and anti-
G-CSF mAb both failed to reverse the effect of IL-17A (data not shown). 
However, anti-GM-CSF mAb strongly suppressed the indirect effect of IL-
17A on Ly6Chi monocytes (Figure 35A). Moreover, the phenotype of 
monocytes co-cultured with rGM-CSF resembled monocytes from the 
rIL17A-stimulated co-culture (Figure 35A). Therefore, IL-17A induces 
GM-CSF production from cardiac fibroblasts, which mediates the 
proinflammatory differentiation of Ly6Chi monocytes. 
 
Il17ra-/- Mice Have Less Proinflammatory Ly6Chi MO/MΦs 
Infiltration in vivo 
We have shown that IL-17A instructs proinflammatory differentiation of 
Ly6Chi monocytes by inducing GM-CSF production in vitro (Figure 35A). 
To investigate whether IL-17A drives MO/MΦs into a proinflammatory 
phenotype in the heart, we isolated Ly6Chi MO/MΦs from the hearts of 
WT or Il17ra-/- mice at the peak of inflammation (day 21). Since IL-17A 
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directs proinflammatory changes in monocytes in vitro, we expected that 
Ly6Chi MO/MΦs from Il17ra-/- mice hearts would possess a less 
inflammatory phenotype due to lack of IL-17RA signaling. qPCR assay 
showed that Ly6Chi MO/MΦs from Il17ra-/- mice hearts produced lower 
levels of proinflammatory cytokines Il1b, Il6 (Figure 37A), mirroring the 
phenotype observed from in vitro co-culture experiments. Importantly, 
Ly6Chi monocytes isolated from the spleens of Il17ra-/- mice had 
expression of Il1b and Il6 comparable to WT splenic Ly6Chi monocytes 
(Figure 38), demonstrating that the effects of IL-17A on MO/MΦs was a 
local phenomenon specific to the heart during EAM. 
To confirm the in vitro results that GM-CSF mediates these effects, we 
injected immunized WT mice with rGM-CSF 36 hours and 12 hours 
before sacrifice on day 21 of EAM, and isolated Ly6Chi MO/MΦs from the 
hearts by FACS. qPCR analysis showed that Ly6Chi MO/MΦs from the 
hearts of rGM-CSF treated mice had higher levels of Il1b and Il6 
expression compared to controls injected with PBS (Figure 37B), 
illustrating that GM-CSF elicits proinflammatory polarization of Ly6Chi 
MO/MΦs MO/MΦs during EAM and DCMi. 
Thus, we confirmed our previous in vitro results in vivo, underscoring 
that this IL-17A à cardiac fibroblast à GM-CSF à monocyte pathway 
directs the development of DCMi after EAM. However, Ly6Chi MO/MΦs 
from Il17ra-/- mice expressed comparable levels of Il12a, Nos2 and Il10 
(not shown), which is not consistent with the findings from in vitro co-
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culture experiment. This difference highlights the complexity of the in 
vivo inflammatory environment and suggests that other pathways play a 
role in the programing of MO/MΦs at the site of inflammation. 
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3.2 Discussion 
About 9-16% of patients with myocarditis progress to dilated 
cardiomyopathy (Herskowitz et al., 1993; Sagar et al., 2011), but there 
are no reliable biological markers that would help identify myocarditis 
patients with high risk of progressing to DCMi (Cooper, 2009). Currently, 
a definitive diagnosis of myocarditis depends upon a biopsy of the 
myocardium. Based on the Dallas criteria, the heart is evaluated based 
on the presence and density of inflammatory infiltration and 
cardiomyocyte death (Aretz et al., 1987). However, our study clearly 
shows that not only the quantity, but also the quality of these infiltrating 
cells is critical in predicting the development of DCMi. Similar to Il17a–/– 
mice, Il17ra–/– mice developed myocarditis and had overall CD45+ cell 
infiltration comparable to WT, but were nonetheless not susceptible to 
DCMi. This protection is associated with a different infiltration profile. 
Il17ra–/– mice had diminished infiltration of neutrophils, which have been 
implicated in inducing cardiac damage and rupture in a myocardial 
infarction model (Hiroi et al., 2013; Vinten-Johansen, 2004). In addition, 
Il17ra–/– mice had significantly less infiltration of proinflammatory 
monocytes and lower Ly6Chi to Ly6Clo MO/MΦ ratios specifically in their 
heart, which represents a potentially useful biomarker for DCMi risk in 
myocarditis patients. 
Monocytes and macrophages are key effector cells in EAM (Barin et al., 
2012) as well as in human giant cell myocarditis (Cooper et al., 2007). 
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MO/MΦs are not a homogeneous population (Hashimoto et al., 2011). 
However, cardiac disease literature tended to ignore their heterogeneity 
until recently, leading to substantial disagreement in reported findings. 
During early development, progenitor cells migrate into solid organs and 
develop into tissue resident macrophages, which are maintained by local 
proliferation with minimal replenishment from blood monocytes 
(Hashimoto et al., 2013; Yona et al., 2013). During an inflammatory 
process, blood monocytes rapidly migrate to the site of inflammation, 
where they mature into macrophages in response to local stimulating 
signals (Sica and Mantovani, 2012). In mouse, monocytes forms two 
major subsets in blood, CCR2hiCX3CR1loLy6Chi (resembling human 
CD14hiCD16- monocytes) and CCR2loCX3CR1hiLy6Clo (resembling human 
CD14loCD16+ monocytes) (Geissmann et al., 2003; Shi and Pamer, 2011).  
In our study, the balance of these two MO/MΦs subsets in the heart 
determines the outcome of inflammation. Thus IL-17RA deficiency leads 
to a lower Ly6Chi/Ly6Clo ratio and protection from DCMi. We found that 
heart-infiltrating Ly6Chi MO/MΦs had a proinflammatory and profibrotic 
phenotype. The proinflammatory cytokines and TGFβ activators they 
produce are likely to play critical roles in cardiac remodeling. Ly6Clo 
monocytes in heart produced high levels of MMPs and IGF-1, which have 
been described as protective in fibrosis (Ramachandran et al., 2012; 
Bessich et al., 2013). We used two methods to manipulate the balance of 
Ly6Chi and Ly6Clo MO/MΦs to demonstrate the role they play in DCMi: 
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First, depletion of Ly6G-CD11b+ MO/MΦs by clodronate-loaded 
liposomes also lowered the ratio of Ly6Chi to Ly6Clo MO/MΦs in the heart. 
Second, PBS-loaded liposomes specifically lowered the ratio of Ly6Chi to 
Ly6Clo MO/MΦs without affecting the total number of MO/MΦs in the 
heart. Neither method induced any change in severity of myocarditis, but 
both protected mice from cardiac fibrosis and the development of severe 
DCMi, demonstrating that Ly6Chi MO/MΦs aggravate the development of 
DCMi. Similarly, in a heart ischemia/reperfusion model, early 
recruitment of Ly6Chi monocytes is associated with injury, preceding the 
recruitment of Ly6Clo monocytes, which appear to be involved in 
myocardial healing (Nahrendorf, 2012). Ly6Clo monocytes were shown to 
be able to arrest and reverse fibrosis in a model of CCl4-induced liver 
damage (Ramachandran et al., 2012). 
We further suggest that the M1/M2 paradigm does not perfectly overlap 
with Ly6Chi and Ly6Clow subsets and does not accurately describe these 
two different populations in the heart during EAM. Traditionally, M1 
represents a population that promotes inflammation whereas M2 is 
responsible for tissue repair and fibrosis (Gordon and Taylor, 2005). 
However, in our EAM model, Ly6Chi MO/MΦs have a proinflammatory 
and profibrotic phenotype. They upregulate both classic M1 markers like 
Tnf and Nos2, as well as M2 markers like Chi3l3, while Ly6Clo MO/MΦs 
produced molecules that are believed to help resolve fibrosis 
(Ramachandran et al., 2012; Bessich et al., 2013).  
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We have shown previously that MO/MΦs express receptors for IL-17A 
but direct stimulation of MO/MΦs with IL-17A does not induce a 
proinflammatory phenotype (Barin et al., 2012). Bone marrow chimeras 
revealed that deficiency of IL-17A/IL-17RA signaling in non-
hematopoietic cells is sufficient to suppress the augmentation of immune 
response and protect mice from cardiac damage. In addition, IL-17A 
signaling to cardiac resident cells was essential for the IL-17A driven 
recruitment of neutrophils and Ly6Chi monocytes to the inflamed heart.  
A recent study found that IL-17A was able to induce apoptosis in 
neonatal cardiomyocytes in vitro (Liao et al., 2012). The authors 
suggested that this effect contributed to cardiomyocyte death during 
myocardial infarction in adult mice. Other investigators reported that IL-
17A induced collagen production in neonatal cardiac fibroblasts (Liu et 
al., 2012). However, neonatal cells have unique properties that are not 
retained in adult cells and are not necessarily the appropriate model to 
study adult diseases. We observed that IL-17A neither induced apoptosis 
nor activated the NF-κB pathway in primary adult cardiomyocytes in vitro, 
indicating that cardiomyocytes are not likely to be the primary target of 
IL-17A in adults. In addition, IL-17A did not directly stimulate collagen 
production in adult cardiac fibroblasts.  
In contrast, adult cardiac fibroblasts respond to IL-17A by producing 
high levels of chemokines and cytokines known to facilitate myeloid cell 
recruitment and instruct their in situ differentiation towards an 
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inflammatory phenotype. Cardiac fibroblasts isolated from Il17ra-/- mice 
during EAM expressed significantly lower levels of proinflammatory 
cytokines and chemokines. Importantly, although it was reported that 
endothelial cells react to IL-17A stimulation, they produced minimal 
amount of cytokines and chemokines compared with cardiac fibroblasts, 
hence endothelial cells do not appear to be the primary target o IL-17A in 
our model of EAM and DCMi. Thus, our study highlights the central, 
decisive role “non-immune” cells like fibroblasts can play in immunologic 
processes. Cardiac fibroblasts served as a critical mediator between 
adaptive and innate immune cells and actively participated in the 
augmentation of immune response. In response to IL-17A stimulation 
from adaptive T cells, cardiac fibroblasts produce granulocytic and 
monocytic chemokines to recruit innate effector cells and aggravate the 
immune response. Cardiac fibroblasts also secrete cytokines, in this case 
GM-CSF, to direct these recruited MO/MΦ effectors to a more 
proinflammatory phenotype, which further intensifies inflammation. 
Moreover, this mediator role played by cardiac fibroblasts proved crucial 
in DCMi, as deficiency of IL-17A/IL-17RA signaling in non-hematopoietic 
cells was sufficient to protect mice from cardiac damage. 
Our studies also revealed that the main mediator of local 
communications between cardiac fibroblasts and MO/MΦs was cardiac 
fibroblast-derived GM-CSF. GM-CSF is known to elicit the expansion and 
differentiation of progenitors of the myeloid lineages; GM-CSF also 
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supports the survival and activation of effector functions of myeloid cells 
(Papatriantafyllou, 2011). In ischemic heart disease, although associated 
with poor prognosis (Maekawa et al., 2004), GM-CSF has been studied 
largely for its role outside of its immunologic functions. These 
mechanisms mostly involve angiogenesis or the mobilization of HSC-like 
cells (Zbinden et al., 2005). There have also been attempts to study the 
role of GM-CSF in myocarditis: Blyszczuk et al. argued that GM-CSF 
does not affect dendritic cell functions during the effector phase of EAM 
(Blyszczuk et al., 2013); however, they neglected to address the effects of 
GM-CSF on MO/MΦs, and their impact on cardiac damage. Our data 
now point to GM-CSF acting as a key mediator of IL-17A-driven 
autoimmunity in DCMi: IL-17A signaling induces GM-CSF production 
from cardiac fibroblasts. GM-CSF then drives differentiation of heart-
infiltrating MO/MΦs toward a proinflammatory phenotype that in turn 
promotes DCMi. 
In conclusion, our study demonstrates that the IL-17A/IL-17RA axis is 
critical in the development of DCMi, a fatal inflammatory heart disease. 
IL-17A induces chemokine production by cardiac fibroblasts, resulting in 
an infiltrate rich in neutrophils and Ly6Chi MO/MΦs in the heart. 
Furthermore, IL-17A directs monocytic infiltrates into an even more 
inflammatory phenotype by inducing GM-CSF production from cardiac 
fibroblasts. This novel pathway provides new potential markers to 
identify myocarditis patients with a high risk of developing DCMI. This 
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pathway further suggests new targets for the prevention of DCMi. In 
addition, other groups have shown that IL-17A is critical in inflammatory 
diseases including myocardial ischemia/reperfusion injury (Liao et al., 
2012), pulmonary fibrosis (Wilson et al., 2010) and liver cirrhosis (Kono 
et al., 2011). The pathway involving IL-17A, fibroblasts, GM-CSF, and 
MO/MΦs may therefore play a key role in many other diseases. 
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3.3 Figures and Tables 
Figure 21. Il17ra-/- mice are protected from DCMi 
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Figure 23. Il17ra-/- mice are protected from DCMi 
80 
Figure 24. IL-17RA deficiency alters the composition of heart-
infiltrating cells 
81 
Figure 25. IL-17RA deficiency has no effects on infiltration of CD4+
T cell and SiglecF+ eosinophil in the heart or the balance of Ly6Chi
and Ly6Clo monocytes in the spleen 
82 
Figure 26. Transcriptomes and functions of intracardiac Ly6Chi and 
Ly6Clo MO/MΦs 
83 
Figure 27. Manipulation of Ly6Chi and Ly6Clo MO/MΦs protects mice 
from DCMi 
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Figure 28. IL-17RA signaling to cardiac resident cells is required for 
the development of DCMi 
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Figure 29. IL-17RA signaling to cardiac resident cells is required for 
the development of DCMi 
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Figure 30. IL-17A has no significant effects on adult mouse 
cardiomyocytes in vitro 
87 
Figure 31. IL-17A stimulates the production of myeloid chemokines 
















































































































































































	   88 
 
Figure 32. IL-17A stimulates the production of myeloid chemokines 
and cytokines in adult cardiac fibroblasts in vitro 
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Figure 33. Cardiac fibroblasts react to IL-17A to produce 
proinflammatory cytokines and chemokines in vivo 
	   90 
 
Figure 34. Cardiac fibroblasts react to IL-17A to be the dominant 
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Figure 35. IL-17A drives the differentiation of monocytes in trans 
through cardiac fibroblasts and GM-CSF but has no effect in the 
balance of Ly6Chi and Ly6Clo populations 
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Figure 36. Specificity of IL-17A in indirectly driving the 
differentiation of monocytes   
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Figure 37. IL-17A and GM-CSF drive cardiac infiltration of Ly6Chi 
MO/MΦs into proinflammatory phenotype in vivo   
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Figure 38. The effects of IL-17A in driving the polarization of Ly6Chi 
MO/MΦs is local 
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Table III Transcriptomes of intracardiac Ly6Chi and Ly6Clo MO/MΦs 
Gene 
Ly6Chi MO/MΦ Ly6Clo MO/MΦ p 
Value 
Ly6Chi/Ly6Clo 
Ratio GeoMean 95% CI GeoMean 95% CI 
Ccr2 2.97E+00 (2.49E+00, 3.45E+00) 2.10E+00 (1.94E+00, 2.26E+00) 0.0270 1.41 
Il1b 7.54E+01 (6.40E+01, 8.68E+01) 1.97E+01 (1.48E+01, 2.45E+01) 0.0009 3.84 
Il6 1.80E+00 (1.14E+00, 2.47E+00) 2.51E-01 (1.58E-01, 3.43E-01) 0.0093 7.19 
Il12a 7.55E-02 (4.03E-02, 1.11E-01) 1.65E-03 (0, 1.03E-02) 0.0170 45.78 
Tnf 2.36E+00 (1.39E+00, 3.33E+00) 7.83E-01 (3.67E-01, 1.20E+00) 0.0392 3.02 
Lyz2 1.42E+02 (9.97E+01, 1.85E+02) 7.17E+01 (5.03E+01, 9.30E+01) 0.0411 1.99 
Nos2 7.13E-02 (3.44E-02, 1.08E-01) 1.57E-02 (1.05E-02, 2.09E-02) 0.0341 4.54 
Thbs1 2.68E+00 (1.39E+00, 3.98E+00) 3.83E-01 (3.25E-01, 4.42E-01) 0.0199 7.00 
Arg2 1.33E+00 (1.09E+00, 1.58E+00) 4.83E-01 (1.93E-01, 7.73E-01) 0.0136 2.76 
Chi3l3 6.80E-01 (4.10E-01, 9.50E-01) 6.28E-02 (1.51E-02, 1.11E-01) 0.0105 10.83 
Cx3cr1 1.00E+00 (3.84E-01, 1.63E+00) 2.39E+00 (2.09E+00, 2.70E+00) 0.0212 0.419 
Igf1 6.10E-05 (8.28E-06, 1.14E-04) 2.66E-02 (1.15E-02, 4.16E-02) 0.0207 0.002 
Mmp9 6.12E-03 (0, 1.49E-02) 3.01E-02 (2.34E-02, 3.68E-02) 0.0194 0.203 
Mmp12 1.57E-01 (0, 3.59E-01) 1.15E+00 (7.77E-01, 1.51E+00) 0.0103 0.137 
 
EAM and DCMi were induced in WT mice. Mice were sacrificed 21days 
post-immunization. Ly6G-CD11b+Ly6Chi (Ly6Chi) and Ly6G-CD11b+Ly6Clo 
(Ly6Clo) MO/MΦ populations were isolated from mouse hearts by FACS. 
mRNA levels were determined by real-time qPCR and normalized to the 
levels of housekeeping gene Hprt. Geometric mean of 3 replicates and 
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95% confidence interval (95% CI) are shown. The ratios of the mRNA 
levels in Ly6Chi population to Ly6Clo population are calculated. Data are 
analyzed by unpaired two-tailed Student’s t test. 
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Table IV Purity of Cardiac Fibroblast Culture 
Gene 
Cardiac Fibroblast Culture BMDM Culture 
GeoMean 95% CI GeoMean 95% CI 
Agtr1a 4.29E-03 (2.06E-03, 6.53E-03) Not Detected 
Ddr2 7.19E-01 (5.60E-01, 8.77E-01) Not Detected 
Ccr2 Not Detected 1.70E-01 (2.96E-02, 3.11E-01) 
Cx3cr1 Not Detected 1.47E-02 (5.26E-03, 2.42E-02) 
Mpo Not Detected 2.80E-02 (6.60E-03, 4.93E-02) 
Pgcd1lg2 Not Detected 3.86E-01 (4.53E-02, 7.26E-01) 
 
Primary adult mouse cardiac fibroblasts (CFs) and bone marrow derived 
macrophages (BMDMs) were isolated from WT BALB/cJ mice and 
cultured separately. RNA was isolated from CF and BMDM cultures of 
105 cells. mRNA levels of fibroblast-specific genes (Agtr1a and Ddr2) and 
myeloid cell-specific genes (Ccr2, Cx3cr1, Mpo and Pgcd1lg2) were 
determined by real-time qPCR and normalized to housekeeping gene Hprt. 
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3.4 Figure Legends 
Figure 21. Il17ra-/- mice are protected from DCMi 
EAM and DCMi were induced in WT and Il17ra-/- mice. 63 days post-
immunization, naïve and immunized mice underwent echocardiography 
and were sacrificed. This experiment was independently performed three 
times with similar results. 
(A) Representative histopathology of Il17ra-/- and WT mice hearts showing 
Masson’s trichrome blue staining. Fibrotic tissue was stained blue. 2.5X 
magnification. Scale bars represent 1mm. 
(B) Cardiac fibrosis in Il17ra-/- and WT mice scored using Masson’s 
trichrome blue staining. 
(C) Cardiac hydroxyproline assay normalized to heart weight. 
(D) Representative M-Mode echocardiography of naïve, WT and Il17ra-/- 
mice. 
(E) Ejection fraction (%) of naïve, WT and Il17ra-/- mice by 
echocardiography. Dash line marks 60%, the threshold for severe DCMi. 
(B), (C) and (E) Data points represent individual mice. Bars represent 
mean. Data were analyzed by one-way ANOVA followed by Tukey’s post-
test. *, p<0.05; **, p<0.01; ****, p<0.0001. 
 
Figure 22. Il17ra-/- mice develop EAM comparable to WT and Il17a-/- 
mice 
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EAM and DCMi were induced in WT, Il17a-/- and Il17ra-/- mice. Mice were 
sacrificed 21 days post-immunization. This experiment was 
independently performed three times with similar results. 
(A) Representative histopathology of WT, Il17a-/- and Il17ra-/- mice hearts 
showing H&E staining. 10X magnification. 
(B) EAM in WT, Il17a-/- and Il17ra-/- mice scored using H&E staining. 
Data points represent individual mice. Bars represent mean. Data are 
analyzed by Kruskal-Wallis test followed by Dunn’s procedure. 
 
Figure 23. Il17ra-/- mice are protected from DCMi 
EAM and DCMi were induced in WT and Il17ra-/- mice. 63 days post-
immunization, naïve and immunized mice underwent echocardiography 
and were sacrificed. This experiment was independently performed three 
times with similar results. 
(A) Left ventriclar end-diastolic dimension (LVEDD); (B) Left ventriclar 
end-systolic dimension (LVESD); (C) Fraction shortening (FS); (D) Relative 
wall thickness (RWT) ; (E) Heart weight / body weight ratio (‰) of naïve, 
WT and Il17ra-/- mice by echocardiography. Data points represent 
individual mice. Bars represent mean. Data were analyzed by one-way 
ANOVA followed by Tukey’s post-test. *, p<0.05; ****, p<0.0001. 
 
Figure 24. IL-17RA deficiency alters the composition of heart-
infiltrating cells 
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EAM and DCMi were induced in WT or Il17ra-/- mice. Mice were sacrificed 
21 days post-immunization. The composition of heart-infiltrating cells 
was analyzed by flow cytometry. This experiment was independently 
performed four times with similar results. 
(A) Representative gating of heart-infiltrating myeloid cells. 
(B) Total intracardiac CD45+ leukocytes in WT and Il17ra-/- mice.  
(C) Intracardiac Ly6Ghi neutrophils as a proportion of total CD45+ 
leukocytes. 
(D) Intracardiac Ly6G-CD11b+ MO/MΦs as a proportion of total CD45+ 
leukocytes. 
(E) Ly6Chi MO/MΦs as a proportion of Ly6G-CD11b+ population. 
(F) Ly6Chi to Ly6Clo MO/MΦ ratio. 
(B) ~ (F) Data points represent individual mice. Bars represent mean. 
Data are analyzed by unpaired two-tailed Student’s t test. **, p<0.01. 
 
Figure 25. IL-17RA deficiency has no effects on infiltration of CD4+ 
T cell and SiglecF+ eosinophil in the heart or the balance of Ly6Chi 
and Ly6Clo monocytes in the spleen 
EAM and DCMi were induced in WT and Il17ra-/- mice. Mice were 
sacrificed 21 days post-immunization. The compositions of heart-
infiltrating cells and splenocytes were analyzed by flow cytometry. This 
experiment was independently performed four times with similar results. 
(A) Intracardiac CD4+ T cells as a proportion of total CD45+ leukocytes. 
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(B) Intracardiac SiglecF+ eosinophils as a proportion of total CD45+ 
leukocytes. 
(C) Ly6Chi monocytes as a proportion of total Ly6G-CD11b+ population in 
the spleen. 
(D) Ly6Ghi neutrophils as a proportion of total CD45+ leukocytes in the 
spleen. 
(A) ~ (D) Data points represent individual mice. Bars represent mean. 
Data are analyzed by unpaired two-tailed Student’s t test. ****, p<0.0001. 
 
Figure 26. Transcriptomes and functions of intracardiac Ly6Chi and 
Ly6Clo MO/MΦs 
(A) EAM and DCMi were induced in WT mice. Mice were sacrificed 21 
days post-immunization. Ly6G-CD11b+Ly6Chi (Ly6Chi) and Ly6G-
CD11b+Ly6Clo (Ly6Clo) MO/MΦ populations were isolated from mouse 
hearts by FACS. mRNA levels were determined by real-time quantitative 
PCR, normalized to housekeeping gene Hprt. This experiment was 
independently performed twice with similar results. Detailed data are 
shown in Table S1. For each individual gene, the ratio of its expression 
in Ly6Chi population versus that in Ly6Clo was calculated and plotted in 
log scale. Ratio greater than one indicates the gene was upregulated in 
Ly6Chi MO/MΦs (orange), and ratio smaller than one indicates the gene 
was upregulated in Ly6Clo MO/MΦs (blue).  
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(B) ~ (D) EAM and DCMi were induced in WT mice. On days 14, 16, 18 
and 20, mice were injected i.v. with 250µL PBS (Control), PBS-loaded 
liposome (PBS Liposome) or clodronate-loaded liposome (Clodronate), 
respectively. Mice were sacrificed 21 days post-immunization. The 
composition of heart-infiltrating cells was analyzed by flow cytometry. 
This experiment was independently performed twice with similar results. 
(B) Ly6Chi MO/MΦs as a proportion of Ly6G-CD11b+ population. 
(C) Ly6Chi to Ly6Clo MO/MΦ ratio. 
(D) Intracardiac Ly6G-CD11b+ MO/MΦs as a proportion of total CD45+ 
leukocytes. 
(E) ~ (G) EAM and DCMi were induced in WT mice. From day 14 to day 
35, mice were injected i.v. every other day with 250µL PBS (Control), 
PBS-loaded liposome (PBS Liposome) or clodronate-loaded liposome 
(Clodronate), respectively. 63 days post-immunization, mice underwent 
echocardiography and were sacrificed. This experiment was 
independently performed twice with similar results. 
(E) Ejection fraction (%) by echocardiography. Dash line marks 60%, the 
threshold for severe DCMi. 
(F) Heart weight / body weight ratio (‰). 
(G) Cardiac hydroxyproline assay normalized to heart weight. 
(B) ~ (G) Data points represent individual mice. Bars represent mean. 
Data were analyzed by one-way ANOVA followed by Tukey’s post-test. *, 
p<0.05; **, p<0.01; ***, p<0.001. 
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Figure 27. Manipulation of Ly6Chi and Ly6Clo MO/MΦs protects mice 
from DCMi 
(A) and (B) EAM and DCMi were induced in WT mice. On days 14, 16, 18 
and 20, mice were injected i.v. every with 250µL PBS (Control), PBS-
loaded liposome (PBS Liposome) or clodronate-loaded liposome 
(Clodronate), respectively. Mice were sacrificed 21 days post-
immunization. This experiment was independently performed twice with 
similar results. 
(A) EAM severity in mice treated with PBS, PBS-loaded or clodronate-
loaded liposomes were scored using H&E staining. Data points represent 
individual mice. Bars represent mean. Data are analyzed by Kruskal-
Wallis test followed by Dunn’s procedure. 
(B) The composition of heart-infiltrating cells was analyzed by flow 
cytometry, showing Ly6Ghi neutrophils as a proportion of total CD45+ 
leukocytes. 
(C) ~ (D) EAM and DCMi were induced in WT mice. From day 14 to day 
35, mice were injected i.v. every other day with 250µL PBS, PBS-loaded 
liposome or clodronate-loaded liposome, respectively. 63 days post-
immunization, mice underwent echocardiography. This experiment was 
independently performed twice with similar results. (C) Fraction 
shortening (FS) and (D) Left ventriclar end-systolic dimension (LVESD).  
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(B) ~ (D) Data points represent individual mice. Bars represent mean. 
Data were analyzed by one-way ANOVA followed by Tukey’s post-test. *, 
p<0.05; **, p<0.01. 
 
Figure 28. IL-17RA signaling to cardiac resident cells is required for 
the development of DCMi 
(A) Schemiatic of the generation of bone marrow chimeras: bone marrows 
were transferred from WT or Il17ra-/- Thy1.1 donor into lethally irradiated 
Il17ra-/- or WT Thy1.2 recipients. EAM and DCMi were induced 8 weeks 
after transfer.  
(B) and (C) 63 days post-immunization, mice underwent 
echocardiography and were sacrificed. This experiment was 
independently performed four times with similar results. 
(B) Ejection fraction (%) of bone marrow chimeras with depicted 
genotypes.  
(C) Cardiac hydroxyproline assay normalized to heart weight. 
(D) and (E) 21 days post-immunization, mice were sacrificed, and their 
heart-infiltrating cells were analyzed by flow cytometry. This experiment 
was independently performed three times with similar results. 
(D) Ly6Ghi neutrophil as a proportion of intracardiac CD45+ leukocytes in 
bone marrow chimeras with depicted genotype. 
(E) Ly6Chi MO/MΦs as a proportion of intracardiac Ly6G-
CD11b+population. 
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(B) ~ (E) Data points represent individual mice. Bars represent mean. 
Data are analyzed by two-way ANOVA (genotype of donor vs genotype of 
recipient) followed by Tukey’s post-test. *, p<0.05; **, p<0.01; ****, 
p<0.0001. 
 
Figure 29. IL-17RA signaling to cardiac resident cells is required for 
the development of DCMi 
(A) Primary adult mouse cardiomyocytes and cardiac fibroblasts were 
isolated from naïve WT mice. mRNA of Il17ra and Il17rc were detected by 
real-time qPCR. Data are shown as Mean+SEM of 3 replicates. 
(B) and (C) Bone marrow chimeras were generated by transferring bone 
marrow from WT or Il17ra-/- Thy1.1 donor mice into lethally irradiated 
Il17ra-/- or WT Thy1.2 recipients. EAM and DCMi were induced 8 weeks 
after transfer. 63 days post-immunization, mice underwent 
echocardiography and were sacrificed. This experiment was 
independently performed four times with similar results. 
(B) LVESD of bone marrow chimeras with depicted genotypes. 
(C) Fraction shortening (%) of bone marrow chimeras with depicted 
genotypes. 
(B) and (C) Data points represent individual mice. Bars represent mean. 
Data are analyzed by two-way ANOVA (genotype of donor vs genotype of 
recipient) followed by Tukey’s post-test. **, p<0.01; ***, p<0.001; ****, 
p<0.0001. 
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Figure 30. IL-17A has no significant effects on adult mouse 
cardiomyocytes in vitro 
(A) and (B) Primary adult mouse cardiomyocytes (CMs) were cultured 
with or without rIL-17A (100ng/mL) for 24 hours. This experiment was 
independently performed three times with similar results. 
(A) Bright field microscopy (10X) showed cell morphology and viability of 
rIL-17A-treated and control CMs. Scale bars represent 100µm. 
(B) Viable CMs were counted in 5 different fields (10X). Data are shown 
as Mean+SEM and analyzed by unpaired two-tailed Student’s t test. 
(C) Primary adult CMs were stimulated with rIL-17A (100ng/mL) for 
15min, 30min or 60min. Western blot detected no degradation of IκBα in 
rIL-17A treated CMs. 
 
Figure 31. IL-17A stimulates the production of myeloid chemokines 
and cytokines in adult cardiac fibroblasts in vitro 
(A) Primary adult mouse cardiac fibroblasts (CFs) and bone marrow 
derived macrophages (BMDMs) were cultured on chamber slides. 
Immunofluorescence microscopy (20X) showed that CFs expressed α-
smooth muscle actin (αSMA) (green) but not CD11b (red). BMDMs were 
stained with isotype-matched antibodies as isotype control. Scale bars 
represent 100µM.  
	   107 
(B) The expression of surface markers CD44 and CD45 in CF (filled) and 
BMDM (open) cultures were analyzed by flow cytometry. Levels of 
expression on all 7-AAD-negative viable cells from respective cultures 
were plotted on histograms. 
(C) CFs were cultured with rIL-17A (100ng/mL), rTNFα (5ng/mL) or two 
cytokines combined for 24 hours. Supernatant were collected after 
culture, and the levels of CXCL1, CCL2, GM-CSF, G-CSF, IL-6 and LIF 
were measured by ELISA. These experiment were independently 
performed three times with similar results. Data are shown as 
Mean+SEM of 3 replicates and analyzed by one-way ANOVA followed by 
Tukey’s post-test. ***, p<0.001; ****, p<0.0001. 
 
Figure 32. IL-17A stimulates the production of myeloid chemokines 
and cytokines in adult cardiac fibroblasts in vitro 
Primary adult mouse cardiac fibroblasts (CFs) from naïve WT mice were 
cultured with rIL-17A (100ng/mL), rTNFα (5ng/mL) or two cytokines 
combined for 6 hours. RNA were isolated from CFs and the mRNA levels 
of (A) Cxcl1, Ccl2, Csf2, Csf3, Il6 and Lif; (B) Col1a1 and Col3a1; (C) 
Cx3cl1 were determined by real-time qPCR and normalized to 
housekeeping gene Hprt. These experiment were independently 
performed three times with similar results. Data are shown as 
Mean+SEM of 3 replicates and analyzed by one-way ANOVA followed by 
Tukey’s post-test. *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001. 
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Figure 33. Cardiac fibroblasts react to IL-17A to produce 
proinflammatory cytokines and chemokines in vivo 
EAM and DCMi were induced in WT and Il17ra-/- mice. Mice were 
sacrificed 21 days post-immunization. CD45-CD34+CD146+CD44hiCD31- 
cardiac fibroblasts (CFs) and CD45-CD34+CD146+CD44loCD31hi 
endothelial cells (ECs) were isolated from mouse hearts by FACS. This 
experiment was independently performed twice with similar results.  
(A) Representative gating of CFs and ECs. 
(B) mRNA levels of Cxcl1, Csf2, Csf3 and Il6 in CFs from WT and Il17ra-/- 
mice were determined by real-time quantitative PCR and normalized to 
housekeeping gene Hprt. Data are shown as Mean+SEM of 3 replicates 
and analyzed by unpaired two-tailed Student’s t test. *, p<0.05; ***, 
p<0.001. 
 
Figure 34. Cardiac fibroblasts react to IL-17A to be the dominant 
source of proinflammatory cytokines and chemokines in vivo 
EAM and DCMi were induced in WT and Il17ra-/- mice. Mice were 
sacrificed 21 days post-immunization. CD45-CD34+CD146+CD44hiCD31- 
cardiac fibroblasts (CFs) and CD45-CD34+CD146+CD44loCD31hi were 
isolated from mouse hearts by FACS. This experiment was independently 
performed twice with similar results. 
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(A) mRNA levels of Ccl2 and Lif in CFs from WT and Il17ra-/- mice were 
determined by real-time quantitative PCR and normalized to 
housekeeping gene Hprt. 
(B) mRNA levels of Ccl2, Cxcl1, Csf2, Csf3, Il6 and Lif in CFs and ECs 
from WT mice were determined by real-time quantitative PCR and 
normalized to housekeeping gene Hprt.  
(A) and (B) Data are shown as Mean+SEM of 3 replicates and analyzed by 
unpaired two-tailed Student’s t test. *, p<0.05; ***, p<0.001; ****, 
p<0.0001. 
 
Figure 35. IL-17A drives the differentiation of monocytes in trans 
through cardiac fibroblasts and GM-CSF but has no effect in the 
balance of Ly6Chi and Ly6Clo populations 
(A) Ly6G-CD11c-CD11b+F4/80-Ly6Chi spleen monocytes were isolated 
from naïve Il17ra-/- mice by FACS, and co-cultured with primary adult 
cardiac fibroblasts (CFs) from naïve WT mice for 48 hours under various 
conditions as depicted. mRNA were isolated from FACS-sorted monocytes 
in the end of co-culture. The mRNA levels of Il1b, Il6, Il12a, Nos2 and Il10 
were measured by real-time qPCR, and normalized to Hprt. This 
experiment was independently performed three times with similar results. 
(B) Ly6G-CD11c-CD11b+F4/80- splenic monocytes with mixed Ly6Chi and 
Ly6Clo populations were isolated from naïve WT mice by FACS, and 
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stimulated with 100ng/mL rIL-17A for 48 hours. Ly6Chi monocyte as a 
proportion of total was analyzed by flow cytometry. 
(C) Ly6G-CD11c-CD11b+F4/80- splenic monocytes with mixed Ly6Chi and 
Ly6Clo populations were isolated from naïve Il17ra-/- mice by FACS, and 
cultured alone (Medium), with WT CFs (CF), or with WT CF and rIL-17A 
(CF+IL-17A) for 48 hours. Ly6Chi monocytes as a proportion of total was 
analyzed by flow cytometry. 
(A) ~ (C) Data are shown as Mean+SEM of 3 replicates and analyzed by 
(A) and (C) one-way ANOVA followed by Tukey’s post-test, or (B) unpaired 
two-tailed Student’s t test. *, p<0.05; **, p<0.01; ***, p<0.001; ****, 
p<0.0001. 
 
Figure 36. Specificity of IL-17A in indirectly driving the 
differentiation of monocytes 
Ly6G-CD11c-CD11b+F4/80-Ly6Chi spleen monocytes were isolated from 
naïve Il17ra-/- mice by FACS, and co-cultured with primary adult cardiac 
fibroblasts (CFs) from naïve Il17ra-/- mice for 48 hours with or without 
100ng/mL rIL-17A. mRNA were isolated from FACS-sorted monocytes in 
the end of co-culture. The mRNA levels of Il1b, Il6, Il12a, Nos2 and Il10 
were measured by real-time qPCR, and normalized to Hprt. Data are 
shown as Mean+SEM of 3 replicates and analyzed by unpaired two-tailed 
Student’s t test. 
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Figure 37. IL-17A and GM-CSF drive cardiac infiltration of Ly6Chi 
MO/MΦs into proinflammatory phenotype in vivo 
(A) EAM and DCMi were induced in WT and Il17ra-/- mice. Mice were 
sacrificed 21 days post-immunization. Ly6G-CD11b+Ly6Chi MO/MΦs 
were isolated from mouse hearts by FACS.  
(B) EAM and DCMi were induced in WT mice. Mice were injected i.p. with 
PBS or 0.5µg rGM-CSF 36 hours and 12 hours before day 21 sacrifice. 
Ly6G-CD11b+Ly6Chi MO/MΦs were isolated from mouse hearts by FACS.  
(A) and (B) mRNA levels of Il1b and Il6 were determined by real-time 
quantitative PCR and normalized to housekeeping gene Hprt. This 
experiment was independently performed twice with similar results. Data 
are shown as Mean+SEM of 3 replicates and analyzed by unpaired two-
tailed Student’s t test. *, p<0.05. 
 
Figure 38. The effects of IL-17A in driving the polarization of Ly6Chi 
MO/MΦs is local 
EAM and DCMi were induced in WT and Il17ra-/- mice. Mice were 
sacrificed 21 days post-immunization. Ly6G-CD11b+Ly6Chi MO/MΦs 
were isolated from mouse spleen by FACS. mRNA levels of Il1b, Il6 were 
determined by real-time quantitative PCR and normalized to 
housekeeping gene Hprt. Data are shown as Mean+SEM of 3 replicates 
and analyzed by unpaired two-tailed Student’s t test.	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3.5 Materials and Methods 
Mice  
Il17ra-/- founder mice backcrossed 10 generations from C57BL/6 to 
BALB/c background were provided by Amgen Inc. and Dr. Jay Kolls. WT 
BALB/cJ and CBy.PL(B6)-Thy1a/ScrJ (Thy1.1) founder mice were 
purchased from the Jackson Laboratory. Il17ra-/- mice were crossed to 
Thy1.1 mice and bred to homozygosity at both loci for the generation of 
bone marrow chimeras. All mice were maintained in the Johns Hopkins 
University School of Medicine specific-pathogen free vivarium. Age-
matched WT, Thy1.1 and Il17ra-/- mice bred separately in the Johns 
Hopkins vivarium were used for experiments involving multiple gene 
backgrounds. For experiments conducted exclusively on WT background, 
WT BALB/cJ (000651) mice were purchased from the Jackson 
Laboratory and housed in the Johns Hopkins vivarium for a week before 
immunization. Experiments were conducted on 6-10 week old male mice, 
and in compliance with the Animal Welfare Act and the principles set 
forth in the Guide for the Care and Use of Laboratory Animals. All 
methods and protocols are approved by the Animal Care and Use 
Committee of The Johns Hopkins University. 
Induction of EAM and DCMi  
We employed the myocarditogenic peptide MyHCα614-629 (Ac-
SLKLMATLFSTYASAD) commercially synthesized by fMOC chemistry and 
purified to a minimum of 90% by HPLC (Genscript). On days 0 and 7, 
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mice received axillary s.c. immunizations of 100 µg of MyHCα614-629 
peptide emulsified in CFA (Sigma) supplemented to 5 mg/mL of heat-
killed M. tb strain H37Ra (Difco). On day 0, mice also received 500 ng of 
pertussis toxin i.p. (List Biologicals). 
Assessment of EAM and DCMi Histopathology  
Mice were evaluated for the development of EAM and DCMi on day 21 
and day 63 respectively. Heart tissues were fixed in SafeFix solution 
(Fisher Scientific). Tissues were embedded longitudinally, and 5 µm serial 
sections were cut and stained with H&E or Masson’s Trichrome Blue 
(HistoServ, Gaithersburg, MD). Myocarditis severity was evaluated by 
H&E staining of myocardium area infiltrated with hematopoietic cells, 
according to the following scoring system: grade 0, no inflammation; 
grade 1, less than 10% of the heart section is involved; grade 2, 10-25%; 
grade 3, 25-50%; grade 4, 50-75%; grade 5, more than 75%. Grading was 
performed by grading five sections per heart by two independent, blinded 
investigators and averaged. Cardiac fibrosis was evaluated by measuring 
the area of blue staining of fibrosis as a proportion of heart cross section. 
Echocardiography  
Trans-thoracic echocardiography was performed using the Acuson 
Sequoia C256 ultrasonic imaging system (Siemens). Conscious, depilated 
mice were held in supine position. The heart was imaged in two-
dimensional (2-D) mode in the parasternal short axis view. From this 
mode, an M-mode cursor was positioned perpendicular to the 
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interventricular septum (IVS) and the left ventricular posterior wall 
(LVPW) at the level of the papillary muscles. From M-mode, the wall 
thicknesses and chamber dimensions were measured. For each mouse, 
three to five values for each measurement were obtained and averaged 
for evaluation. The left ventricular end-diastolic dimension (LVEdD), LV 
end-systolic dimension (LVEsD), interventricular septal wall thickness at 
end-diastole (IVSD), and LV posterior wall thickness at end diastole 
(LVPWTED) were measured from a frozen M-mode tracing. Fractional 
shortening (FS), ejection fraction (EF) and relative wall thickness (RWT) 
were calculated from these parameters as previously described 
(Baldeviano et al., 2010). 
Hydroxyproline Assay  
Heart samples were weighed, homogenized in de-ionized water, and then 
hydrolyzed in 6N HCl overnight at 120℃. Lysates are transferred and 
desiccated in 96-well plates, and reconstituted in de-ionized water. After 
incubation with 50 mM Chloramine T (Sigma), followed by 1M 
dimethylaminobenzaldehyde (Sigma), the OD values are read at 570 nm. 
The concentration of hydroxyproline is determined by a 1-100 µg/mL 
standard curve of hydroxyproline (Sigma) and normalized to starting 
heart sample mass.  
Flow Cytometry Analysis and FACS Isolation of Heart Infiltrating 
Cells, CFs and ECs  
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For flow cytometry analysis, single cell suspension were made from 
mouse spleen by gentle dissociation or from mouse hearts by perfusing 
for 3 min with 1x PBS + 0.5% FBS, and digested in GentleMACS C Tubes 
according to manufacturer’s instructions (Miltenyi Biotec). Viability was 
determined by LIVE/DEAD staining according to manufacturer’s 
instructions (Life Techonologies). Cells were blocked with αCD16/32 
(eBiosciences), and surface markers were stained with fluorochrome-
conjugated mAbs (eBioscience, BD Pharmingen, BioLegend). Samples 
were acquired on the LSR II cytometer running FACSDiva 6 (BD 
Immunocytometry). Data were analyzed with FlowJo 7.6 (Treestar 
Software). For FACS isolation, single cell suspension from mouse heart or 
spleen was first purified with a 20% - 80% Percoll (GE Healthcare) 
gradient to eliminate dead cells and debris. Cells were then stained with 
fluorochrome-conjugated mAbs (eBioscience, BD Pharmingen, BioLegend) 
and sorted with Beckman Coulter MoFlo Cell Sorter. 
Treatment of PBS-loaded or clodronate-loaded liposomes and rGM-
CSF during EAM and DCMi  
PBS-loaded and clodronate-loaded liposomes were purchased from 
ClodLip BV (Haalem, the Netherlands). Recombinant mouse GM-CSF was 
purchased from R&D Systems. For liposome treatment, 250µL of PBS, 
PBS-loaded or clodronate-loaded liposomes were injected intravenously 
via the tail vein every other day. For rGM-CSF treatment, PBS or 0.5µg 
rGM-CSF in 200µL PBS were injected i.p.. 
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Real-Time Quantitative PCR  
Tissue total RNA was extracted in TRIZOL (Life Technologies). cDNA were 
synthesized with High Capacity cDNA Reverse Transcription Kit (Life 
Technologies) and amplified with Power SYBR Green Mastermix (Life 
Technologies) in MyiQ2 thermocycler (Bio-Rad) running iQ5 software 
(Bio-Rad). Primer sequences are detailed in Supplemental Data. Data 
were analyzed by the 2–ΔΔCt method of Livak, et al., comparing 
threshold cycles first to Hprt expression, then ΔCt of target genes in 
controls. 
Generation of Bone Marrow Chimera Mice  
Thy1.2+ WT or Il17ra–/– recipient mice were irradiated with two doses of 
600 rad irradiation within 4 hours. 24 hours later they were 
reconstituted with 10 × 106 Thy1.1+ WT or Il17ra–/– donor bone marrow 
cells i.v.. Animals were allowed to reconstitute for a minimum of 8 weeks 
prior to EAM induction. 
Isolation of Primary Adult Mouse CM and CF  
Hearts were dissected from 6-8 week old male mice pre-treated with 
heparin, aorta were cannulated, and hearts were perfused with calcium-
free perfusion buffer, and digested by type II collagenase (Worthington). 
Cardiomyocytes were separated from resulting suspensions by their 
rapid spontaneous precipitation. Isolated cardiomyocytes were cultured 
in mouse laminin-coated plates or chamber slides and used for 
experiments after 24 hours. Cardiac fibroblasts and other cell 
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populations remain in supernatant, and were seeded on uncoated plates 
in DMEM with 4.5g/L glucose, 2mM L-glutamine, 1mM sodium pyruvate, 
25mM HEPES, 100U/mL penicillin G, 100µg/mL streptomycin, 
250ng/mL amphotericin B and 20% FBS. Non-adherent cells were 
washed off after 45 min. Infiltrating hematopoietic cells die off in high 
FBS media due to cytokine exhaustion, resulting in cardiac fibroblast 
culture. 
Western Blot  
Cells were collected in RIPA buffer (Sigma), and total protein was 
quantified by BCA assay (Thermo Scientific). 20µg of sample were 
separated with 10% SDS-PAGE with Mini-Protean precast gels (Bio-Rad). 
After transferred to PVDF membrane (Bio-Rad), IκBα was blotted with 
mAb clone L35A5 (Cell Signaling), and β-actin was blotted with mAb 
clone 13E5 (Cell Signaling). HRP-conjugated secondary antibodies 
(Jackson ImmunoResearch) and Amersham ECL Prime detection system 
(GE Healthcare) was used to visualize the bands. 
Bone Marrow Derived Macrophage  
Bone marrow cells from femur and tibia were isolated from adult WT 
BALB/cJ mice and cultured in DMEM with 4.5g/L glucose, 2mM L-
Glutamine, 1mM sodium pyruvate, 25mM HEPES, 100U/mL penicillin G, 
100µg/mL streptomycin, 55µM 2-mercaptoethanol and 10% FBS 
supplemented with 10ng/mL recombinant M-CSF (R&D Systems) for 8 
days. 
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Immunofluorescence Microscopy  
Cardiac fibroblasts and bone marrow derived macrophages were grown 
on chamber slides (Thermo Scientific). Cells were fixed with 4% 
paraformaldehyde and permeabilized with 0.1% Triton X-100 (Sigma). 
After blocking with donkey serum, cells were incubated with anti-α 
smooth muscle actin (Abcam ab5694) and anti-mouse CD11b 
(ebioscience clone M1/70) antibodies. FITC-conjugated donkey anti-
rabbit and TexasRed-conjugated donkey anti-rat secondary antibodies 
with minimal cross reactivity (Jackson Immunoresearch) were then used. 
Cells were counterstained by DAPI. Images were acquired by Nikon 
Eclipse 90i microscope at 20X magnification and Volocity image analysis 
software (Perkin Elmer). 
ELISA  
Quantitative sandwich ELISA for cell culture supernatants were 
determined by colorimetric ELISA kits according to manufacturers’ 
recommended protocols (R&D Systems). 
Statistics  
Normally distributed data were analyzed by two-tailed Student’s t-test 
(up to two groups), one-way ANOVA followed by Tukey’s post-test or two-
way ANOVA (multiple factor analysis) followed by Tukey’s post-test. EAM 
severity scores were analyzed by Kruskal-Wallis test followed by Dunn’s 
procedure. Values of p < 0.05 were considered statistically significant. 
  








Chapter IV Conclusion 
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IL-23 Drives the Pathogenicity of Autoreactive CD4+ T Cells 
Early studies have established that mouse EAM is a CD4+ T cell – 
dependent disease. As demonstrated in Chapter II, deficiency of IL-23 
resulted in complete resistance to EAM in Il23a-/- mice. Yet, with a BMDC 
transfer model, we showed that even transient IL-23 stimulation from a 
small number of WT antigen presenting cells was sufficient to generate 
pathogenic CD4+ T cells in otherwise resistant Il23a-/- recipients. 
Moreover, IL-23 was dispensable in EAM once a pathogenic autoreactive 
CD4+ T cell population was established, as pathogenic CD4+ T cells 
induced myocarditis in IL23a-/- recipients comparable to WT counterparts. 
To summarize these results, IL-23 stimulation is indispensable in 
generating the pathogenicity of CD4+ T cells in EAM; however, once 
pathogenicity is established in CD4+ T cells, IL-23 is no longer required 
for its maintenance. 
 
The Pathogenicity of Th17 Polarized CD4+ T Cells Rests on Factors 
apart from IL-17A  
Our results confirmed previous findings in other models that IL-23 
deficiency directly impaired Th17 polarization in CD4+ T cells. However, 
it is still unclear what factors produced by Th17 – polarized CD4+ T cells 
are responsible for their pathogenicity. The CD4+ T cell transfer 
experiments illustrated that IL-23 was essential in maintaining IL-17A 
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production in CD4+ T cells, as the lack of IL-23 in recipients significantly 
impaired the ability of transferred CD4+ T cells to continue producing IL-
17A. However, the reduction in IL-17A production had no significant 
effect on the pathogenicity of CD4+ T cells, as Il23a-/- recipients 
developed disease comparable to WT controls. In Chapter III of this 
dissertation, using Il17ra-/- mice, we further demonstrated that the 
pathogenicity of EAM does not rely on the IL-17A signal. 
Resent studies using mouse EAE model indicated that GM-CSF 
production by Th17 polarized CD4+ T cells is crucial in their 
pathogenicity (El-Behi et al., 2011a). The results shown in Chapter II 
indicated that GM-CSF production determines the pathogenicity of CD4+ 
T cells in EAM model as well. First, in the active immunization model, IL-
23 deficiency significantly reduced GM-CSF production in CD4+ T cells, 
concurrent with protection from EAM. Second, in the CD4+ T cell 
transfer experiments, although the lack of IL-23 in recipients reduced IL-
17A production in CD4+ T cells, GM-CSF production remained the same, 
consistent with the disease outcome. 
 
Plasticity of Autoreactive CD4+ T Cells 
As suggested by CD4+ T cell transfer experiments, instead of being 
rigidly committed to a solitarily defined phenotype, Th17 polarized cells 
may convert from a IL-17A-producing phenotype towards a IFNγ -
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producing phenotype, and their pathogenicity was not significantly 
affected during the conversion. Recent studies in the mouse EAE model 
discovered similar pattern (Annunziato and Romagnani, 2010). With the 
help of YFP reporter mice, the investigators reported that the majority of 
IFNγ-producing CD4+ T cells arise from IL-17A producers (Hirota et al., 
2011). 
Although IL-23 is not required once pathogenicity of autoreactive CD4+ T 
cells is established, IL-23 is indispensable in establishing pathogenicity. 
Therefore, it is possible that in order for CD4+ T cells to become a GM-
CSF producer and gain pathogenicity, they first have to undergo a IL-23-
dependent Th17 polarization program. Once GM-CSF production is 
established, IL-23 signaling is no longer required for pathogenicity.  
 
Composition of Heart – Infiltrating Cells Determines the Prognosis 
of Myocarditis 
According to the Dallas criteria, the definitive diagnosis of myocarditis 
depends upon a biopsy of the myocardium, in which the heart is 
evaluated based on the presence and density of inflammatory infiltration 
and cardiomyocyte death (Aretz et al., 1987). However, our study clearly 
shows that not only the quantity, but also the quality of these infiltrating 
cells is critical in predicting the development of DCMi. Il17ra–/– mice 
developed myocarditis and had overall inflammatory infiltration 
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comparable to WT, but were nonetheless protected from DCMi. This 
protection is associated with a different profile of infiltrating cells. Il17ra–
/– mice had diminished infiltration of neutrophils and proinflammatory 
monocytes, and lower ratio of Ly6Chi to Ly6Clo MO/MΦ evident locally in 
the heart. These differences provide potentially useful biomarkers to help 
identify myocarditis patients with high risk of developing DCMi. 
 
Monocytes and Macrophages Are Key Effector Cells during Cardiac 
Inflammation 
MO/MΦs are not a homogeneous population (Hashimoto et al., 2011). In 
mouse, monocytes form two major subsets in blood, 
CCR2hiCX3CR1loLy6Chi (resembling human CD14hiCD16- monocytes) and 
CCR2loCX3CR1hiLy6Clo (resembling human CD14loCD16+ monocytes) 
(Geissmann et al., 2003; Shi and Pamer, 2011). In our study, the balance 
of these two MO/MΦs subsets in the heart determines the outcome of 
inflammation. We observed that heart-infiltrating Ly6Chi MO/MΦs had a 
proinflammatory and profibrotic phenotype, whereas Ly6Clo monocytes in 
heart produced high levels of MMPs and IGF-1, which have been 
described as protective against fibrosis (Ramachandran et al., 2012; 
Bessich et al., 2013). We used two methods to specifically manipulate the 
balance of Ly6Chi and Ly6Clo MO/MΦs, and demonstrated the role they 
play in DCMi: First, depletion of Ly6G-CD11b+ MO/MΦs by clodronate-
loaded liposomes also lowered the ratio of Ly6Chi to Ly6Clo MO/MΦs in 
	   124 
the heart. Second, PBS-loaded liposomes specifically lowered the ratio of 
Ly6Chi to Ly6Clo MO/MΦs without affecting the total number of MO/MΦs 
in the heart. Both manipulations protected mice from cardiac fibrosis 
and the development of severe DCMi, demonstrating that Ly6Chi 
MO/MΦs aggravate the development of DCMi. 
We further suggest that the M1/M2 paradigm does not perfectly overlap 
with Ly6Chi and Ly6Clow subsets and does not accurately describe these 
two different populations in the heart during EAM. Traditionally, M1 
represents a population that promotes inflammation whereas M2 is 
responsible for tissue repair and fibrosis (Gordon and Taylor, 2005). 
However, in our EAM model, Ly6Chi MO/MΦs have a proinflammatory 
and profibrotic phenotype. They upregulate both classic M1 markers like 
Tnf and Nos2, as well as M2 markers like Chi3l3, while Ly6Clo MO/MΦs 
produced molecules that are believed to help resolve fibrosis 
(Ramachandran et al., 2012; Bessich et al., 2013).  
 
Cardiac Fibroblasts Mediate the Effects of IL-17A 
Bone marrow chimera experiments revealed that IL-17A/IL-17RA 
signaling in non-hematopoietic cells is required for the development of 
DCMi. We observed that IL-17A neither induced apoptosis nor activated 
the NF-κB pathway in primary adult cardiomyocytes in vitro, indicating 
that cardiomyocytes are not likely to be the primary target of IL-17A in 
adults. In contrast, adult cardiac fibroblasts respond to IL-17A by 
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producing chemokines and cytokines known to facilitate myeloid cell 
recruitment and instruct their in situ differentiation towards an 
inflammatory phenotype. Cardiac fibroblasts isolated from Il17ra-/- mice 
during EAM expressed significantly lower levels of proinflammatory 
cytokines and chemokines. Importantly, although it was reported that 
endothelial cells react to IL-17A stimulation, they produced minimal 
amount of cytokines and chemokines compared with cardiac fibroblasts. 
Thus, our study highlights the central, decisive role “non-immune” cells 
like fibroblasts can play in immunologic processes. Cardiac fibroblasts 
served as a critical mediator between adaptive and innate immune cells 
and actively participated in the augmentation of immune response.  
In response to IL-17A stimulation from adaptive T cells, cardiac 
fibroblasts produce granulocytic and monocytic chemokines to recruit 
innate effector cells and aggravate the immune response. Cardiac 
fibroblasts also secrete cytokines, in this case GM-CSF, to direct these 
recruited MO/MΦ effectors to a more proinflammatory phenotype, which 
thereby intensifing inflammation. 
 
GM-CSF from Cardiac Fibroblasts Drives Macrophages into 
Proinflammatory Phenotype 
Our studies also revealed that the main mediator of local 
communications between cardiac fibroblasts and MO/MΦs was cardiac 
fibroblast-derived GM-CSF. GM-CSF is known to elicit the expansion and 
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differentiation of progenitors of the myeloid lineages; GM-CSF also 
supports the survival and activation of effector functions of myeloid cells 
(Papatriantafyllou, 2011). In ischemic heart disease, although associated 
with poor prognosis (Maekawa et al., 2004), GM-CSF has been studied 
largely for its role outside of its immunologic functions. These 
mechanisms mostly involve angiogenesis or the mobilization of HSC-like 
cells (Zbinden et al., 2005). Our data point to GM-CSF acting as a key 
mediator of IL-17A-driven autoimmunity in DCMi: IL-17A signaling 
induces GM-CSF production from cardiac fibroblasts. GM-CSF then 
drives differentiation of heart-infiltrating MO/MΦs toward a 
proinflammatory phenotype, which in turn promotes DCMi (Figure 39). 
 
The Sign of Four 
In conclusion, the work presented in this dissertation investigated the 
interactions between CD4+ T lymphocyte and three cytokines, IL-23, IL-
17A and GM-CSF, and demonstrates that the IL-23 – CD4+ T cell – IL-
17A – GM-CSF axis is critical in the pathogenesis of myocarditis and 
DCMi. IL-23 drives the pathogenicity of CD4+ T cells and maintains their 
IL-17A production. IL-17A induces chemokine production by cardiac 
fibroblasts, resulting in an infiltrate rich in neutrophils and Ly6Chi 
MO/MΦs in the heart. Furthermore, IL-17A directs monocytic infiltrates 
into an even more inflammatory phenotype by inducing GM-CSF 
production from cardiac fibroblasts. This novel pathway provides new 
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potential markers to identify myocarditis patients with a high risk of 






Figure 39 Cardiac Fibroblasts Mediate IL-17A-Driven Inflammatory 
Dilated Cardiomyopathy   
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